Relationship between concern for vision loss and self-care management in type 1 and type 2 diabetics by Nkyekyer, Esi
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
9-29-2010
Relationship between concern for vision loss and
self-care management in type 1 and type 2 diabetics
Esi Nkyekyer
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Nkyekyer, Esi, "Relationship between concern for vision loss and self-care management in type 1 and type 2 diabetics" (2010). Yale
Medicine Thesis Digital Library. 162.
http://elischolar.library.yale.edu/ymtdl/162
  
  
 
RELATIONSHIP BETWEEN CONCERN FOR VISION LOSS AND SELF-CARE MANAGEMENT 
IN TYPE 1 AND TYPE 2 DIABETICS. 
 
 
 
 
 
A Thesis Submitted to the  
Yale University School of Medicine  
in Partial Fulfillment of the requirements for the  
Degree of Doctor of Medicine 
 
 
 
 
 
By 
Esi Wusiwa Nkyekyer 
2010 
RELATIONSHIP BETWEEN CONCERN FOR VISION LOSS AND SELF-CARE MANAGEMENT IN TYPE 1 AND 
TYPE 2 DIABETICS 
Esi W. Nkyekyer, Ron A. Adelman. Department of Ophthalmology,Yale University, School of Medicine, New Haven, 
CT. 
 
The purpose of this study is to assess the following hypotheses: concern for vision loss is associated with 
self-care behavior and glucose control; concern for overall diabetes complications is associated with self-care behavior 
and glucose control; concern for vision loss accounts for a significant proportion of the association between concern for 
overall diabetes complications and self-care behavior and glucose control in Type 1 and Type 2 diabetic subjects.  
The study sample consists of 100 participants (24 Type 1 diabetics, 69 Type 2 diabetics, 7 unknown) over 
the age of 18 presenting to the Yale Diabetes Center from June 2009 to August 2009.  In addition to demographic and 
health-related surveys, the following questionnaires were administered:  Visual Functioning Questionnaire (VFQ), Fear 
of Complications Questionnaire (FCQ), and Summary of Diabetes Self-Care Activities (SDSCA) questionnaire. The 
VFQItem 3 score is used to measure concern for overall eyesight (lower scores correlate with greater concern); the 
FCQVision score to measure concern for potential vision loss (lower scores correlate with decreased concern); the 
FCQComposite score to measure concern for overall diabetes complications (lower scores correlated with decreased 
concern); and the SDSCAComposite score to measure self-care behavior (lower scores correlate with poorer self-care 
behavior). Spearman Correlation analysis, Linear Regression analysis, ANCOVA and ANOVA are used to assess 
relationships between VFQ, FCQ, SDSCA composite and subscale scores and HgA1c.  The main outcome measures 
are self-care behavior and HgA1c.   
Results show that in the Type 1 Diabetes group, lower SDSCAComposite scores  correlate with lower VFQItem 3 
scores (rSpearman=0.521, p=0.009). The correlation is further confirmed by linear regression analysis.  For the Type 2 
Diabetics group, there is a statistically significant positive linear relationship between HgA1c levels and FCQVision (FLinear 
(1,53) = 7.56, p = 0.008, ω=0.468)  and  FCQComposite scores (FLinear  (1,53) =  7.80,  p = 0.007, ω=0.504).   
In conclusion, Type 1 diabetics with poor self-care practices are more concerned about overall eyesight and 
vice versa. Type 2 diabetics with poor glycemic control have greater concern for potential vision loss and overall 
diabetes complications and vice versa. This knowledge may be used to target patient education efforts to effectively 
improve self-care behavior in both Type 1 and Type 2 diabetic populations. Future research is needed to investigate 
factors contributing to these associations.
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1. Introduction 
Diabetes is rapidly on the rise. According to national estimates for 2007, 10.7% of individuals 20 
years and older and 23.1% of all people 60 years and older suffer from diabetes; at least 57 million 
Americans are pre-diabetic and therefore at risk of developing diabetes and its associated 
complications (1). It is well established that poor glycemic control in diabetic patients is associated 
with increased risk for microvascular complications (2, 3). As such, careful management of 
diabetes as a chronic disease is necessary to prevent early onset of these complications (4). This 
management lies in the hands of the patient, health care professionals (primary care physicians, 
internists, endocrinologists, ophthalmologists, nurses), health care institutions and policy-making 
bodies.  The patient is ultimately responsible for eating healthier, maintaining a normal body 
weight, taking medications and monitoring glucose levels. Health care professionals play a pivotal 
role in educating patients about diabetes while addressing their health care needs. Health care 
institutions and policy making bodies take charge of designing cost-effective systems of 
management that provide the necessary infrastructure to optimize patient care. Each level of care 
faces unique challenges when addressing the continued needs of patients with chronic diseases 
such as diabetes. To make productive advances in diabetes management, every facet of the 
collaborative effort must work to develop creative and effective solutions to these challenges.  This 
is particularly important as only 7.3% of diabetic patients meet therapeutic goals for the 3 most 
important measures of risk for diabetes complications: HbA1c level, blood pressure, and low-density 
lipoprotein cholesterol (5). 
 
Diabetic retinopathy is a major microvascular complication of poor glycemic control in diabetic 
patients and the leading cause of new cases of blindness in the United States in persons aged 20 
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to 70 years (1, 3, 6). On average, diabetic patients are more likely to suffer from correctable as well 
as uncorrectable vision loss than their non-diabetic counterparts (7). Among the 10.2 million 
Americans aged 40 and older with diabetes, approximately 1 in 3 have diabetic retinopathy and 1 
in 12 are affected by vision threatening retinopathy (8); in all persons over the age of 18, 1 in 300 
persons has diabetic retinopathy, and in 1 of 600, this retinopathy is vision-threatening (9).  An 
analysis by Roy et al demonstrated that 75 to 82% of persons with Type 1 diabetes have some 
degree of retinopathy, and in 30 to 32% of patients, these retinal changes threaten vision (9).  With 
diabetes on the rise, future projections suggest that diabetic retinopathy will substantially increase 
as a public health problem, particularly in the aging population (10). The number of Americans 40 
years or older with diabetic retinopathy and vision-threatening diabetic retinopathy is expected to 
triple by 2050, from 5.5 million to 16.0 million and from 1.2 million to 3.4 million respectively, with 
increases among those 65 years or older expected to be more pronounced (2.5 million to 9.9 
million for diabetic retinopathy and 0.5 million to 1.9 million for vision-threatening diabetic 
retinopathy) (10).  
 
Ophthalmologists play a significant role in screening diabetic patients for diabetic retinopathy and 
providing temporizing treatments to slow progression from non-proliferative to proliferative disease. 
The purpose of this study is to determine if there is any relationship between patients’ attitudes 
towards diabetes-associated vision loss and their self-care behaviors. By understanding patient 
attitudes and concerns about vision loss, ophthalmologists, in conjunction with primary care 
physicians, nurses and other health professionals may be better positioned to substantially 
influence self-care behavior in the diabetic patient population.  
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a. Impact of Diabetes-Associated Vision Impairment on Diabetic Patients  
Visual impairment in diabetic patients is associated with a spectrum of psychosocial sequelae often 
related to the onset, progression and extent of visual loss. Bernbaum et al (11) observed that 
patients with fluctuating visual impairment from diabetic retinopathy (commonly seen in the initial 
stages of diabetic retinopathy) experienced greater emotional distress and depression than 
patients with stable visual impairment from diabetic retinopathy. Compared with both fully-sighted 
and partially-sighted diabetic patients, Cox et al found that individuals with total visual loss 
experienced greater psychological distress, anxiety, and somatization (12).   
 
Furthermore, visual impairment from diabetic retinopathy has been shown to reduce health-related 
quality of life (HRQoL) measures. Lloyd et al used multiple methods (including EuroQoL (EQ-5D), 
Health State Utilities Index (HUI)-3, and the National Eye Institute Visual Functioning Questionnaire 
(VFQ) to estimate utility loss among patients with varying degrees of vision loss from diabetic 
retinopathy. They showed that a decline in visual acuity from 20/20 to counting fingers was 
significantly associated with a decrease in the majority of utility measures (13).  Sharma et al in a 
review of current literature examining the impact of diabetic retinopathy and diabetic macular 
edema on HRQoL, amassed both qualitative and quantitative evidence for a decrease in HRQoL in 
persons with diabetic retinopathy (14). Furthermore, they found evidence that laser 
photocoagulation can improve health-related quality of life (14). Klein et al examined the 
association between the VFQ composite and subscale scores and visual acuity, diabetic 
retinopathy, and other characteristics in Type 1 diabetics. Their findings demonstrated that lower 
total VFQ scores were independently associated with poorer visual acuity and more severe 
retinopathy (15).  Quality of life areas that are particularly affected by diabetic retinopathy and 
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declining vision include independence, mobility, leisure and social interactions, and self-care 
activities (16, 17). 
 
Although the afore-mentioned studies demonstrate the impact of diabetes-associated vision loss 
on HRQoL measures, a review of the literature utilizing an extensive search of PubMed yielded no 
investigations into how concern for vision loss among diabetics is related to their self-management 
behaviors or glycemic control.  
 
b. Patient Attitudes Towards Diabetes-Associated Vision Loss 
Type 1 and Type 2 diabetic patients have been shown to be primarily concerned about long term 
complications of diabetes such as amputation, cardiovascular disease, nephropathy, neuropathy, 
retinopathy and stroke (18). Loss of vision is of particular concern to a substantial proportion of the 
diabetic population. In patients who have not experienced other complications of diabetes, vision 
loss from diabetic retinopathy is often perceived as the most devastating complication (17). Luckie 
et al assessed the presence and intensity of fear of vision loss among diabetic patients and found 
37% to be preoccupied with this concern and 47.4% to have an intense fear of vision loss (19). 
Furthermore, although visual acuity and the experience of previous laser treatment were predictive 
of the presence of fear in Type 2 diabetics and the diabetic population as a whole, these factors 
only minimally explained reported patient concern, thereby suggesting that predictors of fear of loss 
of vision in the diabetic population are much more complex (19). Although a search of the literature 
yielded no quantitative comparisons between fear of other diabetes complications and fear of 
vision loss, Hendricks et al showed in an exploratory study that diabetic retinopathy is the most 
feared long-term complication among Type 2 diabetic patients (18). 
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Despite the high level of concern for vision loss, many diabetic patients do not have regular eye 
examinations. Both circumstantial factors and patient attitudes to ocular screening prevent diabetic 
patients from attending eye clinics for routine dilated fundoscopic examinations. Circumstantial 
barriers reported in the literature include lack of health insurance, patient finances, lack of time and 
inadequate access to care (20-24). Patient attitudes are often associated with a poor 
understanding of diabetic retinopathy as a microvascular complication of diabetes, and can as such 
affect the regularity with which patients have routine dilated fundoscopic examinations. Lewis et al 
in a qualitative study of diabetic patients demonstrated that lack of awareness of the potential for 
severe yet asymptomatic retinopathy was the greatest barrier to receiving eye care among diabetic 
patients (23). Furthermore, fear of laser treatment and guilt about poor glycemic control deterred 
patients from having regular eye examinations (23).  Moss et al found that among diabetic patients 
who had not had an ocular examination within the past year, the most common reasons for not 
having done so were the absence of eye problems and never being told about the need for an eye 
examination (22).  Minority patients in particular have poor knowledge of the ocular complications 
of diabetes. Among African American diabetic patients, a small proportion have heard of (36%) or 
can correctly describe (8%) diabetic retinopathy, while many (79%) believe there are no effective 
treatments for the disease (25). Finally, the frequency of eye examinations among Hispanic 
individuals is less than the national average; only 36% of newly diagnosed diabetic patients and 
52% of patients with diabetes for more than a year report knowledge of eye disease as a 
consequence of diabetes, while 31% and 48% respectively know the importance of dilated eye 
examinations (26). Lack of knowledge appears therefore to play a significant role in patient 
attitudes towards routine ocular examinations for the detection of diabetic eye disease.  
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c. The Relationship between Concern for Vision Loss and Self-Care behavior among Diabetic 
Patients 
Despite the considerable concern that patients have for vision loss, a search of the literature does 
not reveal many investigations into the relationship between concern for vision loss and overall 
self-care behavior or glycemic control among diabetic patients. Oehler et al, in a descriptive study 
of diabetic patients in group therapy, observed that with deterioration of vision, diabetic patients 
developed an increased awareness of the need for good glycemic control and of the risks of other 
severe diabetic complications (27). Moreover, a quantitative study by Klein et al to examine the 
association of the VFQ composite and specific scale scores with visual acuity, diabetic retinopathy, 
and other characteristics in a cohort of persons with Type 1 diabetes, showed that better glycemic 
control significantly correlated with lower vision-related concern, frustration, irritation and loss of 
independence in patients with Type 1 diabetes (15). Studies investigating similar associations have 
not been performed in patients with Type 2 diabetes. Additionally, the relationship between 
concern for vision loss and measures of diabetes self-care activities has not been investigated. 
Finally, no work has yet been done to determine how diabetic patients’ concern for vision loss 
quantitatively compares to their concern for other long-term complications of diabetes, or the 
proportion of the association between concern for overall diabetes complications and diabetes 
health care activities/glycemic control that is accounted for by concern for vision loss alone. The 
primary aim of this study is therefore to determine if there is any relationship between diabetic 
patients’ concern for vision loss, their self-care behavior and level of glycemic control.  The results 
of such investigations could pave the way for more effective patient-centered approaches to 
improving self-care behavior and disease outcomes in diabetic patients. Understanding how 
patients’ concern for vision loss compares to their concern for other diabetes complications as well 
as its impact on diabetes self-care activities and glycemic control could further motivate health-care 
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providers focus adequate attention on this concern, thereby potentially improving self-care 
behavior and health outcomes for diabetic patients. 
 
2. Specific Hypotheses and Aims 
a. Primary Aims: 
i. To test the hypothesis that, concern for vision loss is associated with diabetes 
self-care activities and glucose control (HgbA1c levels) in diabetic subjects. 
ii. To test the hypothesis that, concern for overall diabetes complications is 
associated with diabetes self-care activities and glucose control (HgbA1c levels) in 
diabetic subjects. 
 
b. Secondary Aim: 
i.  To test the hypothesis that, a significant proportion of the correlation between 
concern for overall diabetes complications and diabetes self-care activities/glucose 
control is accounted for by concern for vision loss in diabetic subjects. 
 
In this study, concern for vision loss was divided into two components: concern for overall 
eyesight which was measured using the VFQItem 3 score, and concern for potential vision 
loss which was measured using the FCQVision score.  
 
3. Methods 
a. Design: This is a cross-sectional observational study of the relationship between 
concern for vision loss/concern for overall diabetes complications and diabetes self-care 
activities/ glycemic control in Type 1 and Type 2 diabetic subjects.  The study was 
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approved as a request for exemption by the Yale University School of Medicine 
Institutional Review Board.  
 
b. Subjects:  One hundred male and female diabetic subjects, over the age of 18 were 
enrolled into the study. No further exclusion and inclusion criteria were defined for this 
study. 
 
c. Intake: All patients presenting to the Yale Diabetes Center for scheduled clinic visits 
were approached for recruitment into the study. This process of recruitment included an 
explanation of the goals of the study, the role the subject would play and an invitation to 
take part in the study.  Interested subjects who agreed to participate were then screened 
for eligibility by being asked their age. Eligible subjects (age over 18) then completed the 
interviewer-administered study assessments either before or after their scheduled clinic 
visit. 
 
d. Assessments: Study assessments include a demographic data sheet, a health 
information sheet, the Visual Functioning Questionnaire (VFQ) (28), the Fear of 
Complications questionnaire (FCQ)   (29) and the Summary of Diabetes Self-care Activities 
(SDSCA)  questionnaire (30). The VFQ, FCQ and SDSCA are all questionnaires that have 
been validated in the literature.  All assessment tools can be found in the Appendix of this 
manuscript. 
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Demographic Data Sheet: 
This questionnaire was used to collect the following demographic data from participants: 
age, gender, language most spoken at home, race, employment status, income, marital 
status and health insurance status. 
 
Health information Sheet: 
This questionnaire was adapted from a similar questionnaire used by Gwira et al in a study 
of factors associated with failure to follow up after glaucoma screening in African American 
patients (31). This questionnaire includes items on glucose control, diabetes 
complications, and family history of diabetes and diabetes complications. Of note, patients 
were asked in this questionnaire to categorize their most recent HgA1c within the past 3 
months.  It is this categorization that was used as the measure of glucose control in this 
study.  
 
National Eye Institute Visual Functioning Questionnaire (VFQ): 
The VFQ is a questionnaire that was created to measure the components of self-reported 
vision-related health status of greatest significance to individuals with chronic eye disease. 
The survey assesses the impact of visual symptoms and disability on health-related quality 
of life domains such as emotional well-being and social functioning.  The VFQ comprises 
the following subscale measures:  general health, general vision, ocular pain, near 
activities, distance activities, social functioning, mental health, role difficulties, dependency, 
driving, color vision, and peripheral vision. Absolute composite and subscale scores on the 
VFQ were converted to percentage scores as described in the VFQ manual (28). I 
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In this study, VFQItem 3 was used as a measure of concern for overall eyesight, that is 
concern related to current subjective vision loss as well as concern about future potential 
vision loss.  Scoring of VFQItem 3  is such that lower scores indicate greater overall concern 
for eyesight. The mental health subscale score (VFQMental Health) was used as a measure of 
vision-associated emotional distress, with lower scores indicating greater emotional 
distress. This subscale score comprises 5 core questions on concern for overall eyesight 
(VFQItem 3), as well as eyesight-associated frustration (VFQItem 21), dependence (VFQItem 22), 
embarrassment (VFQItem 25), and one optional question about eyesight-associated 
irritability (VFQItem A12). All 5 components of the VFQMental Health score were used such that 
the final VFQ survey instrument had 26 items.  
 
Fear of Complications Questionnaire (FCQ): 
The FCQ is a 15-item scale that was designed by Taylor et al to measure fear of diabetes 
complications in patients with Type 1 diabetes (29). The questionnaire comprises items 
related to general fears of diabetes complications, specific fears (e.g. of blindness, kidney 
problems, heart disease), lifestyle fears, and fear of complications associated with poor 
glucose control. Validation of the questionnaire demonstrated that it identified fear that was 
a uniquely diabetes-related emotion, though moderately related to the presence of 
complications and general negative affectivity. Although the original questionnaire was 
scored to only obtain a composite score, in this study the questionnaire was also broken 
down into the following subscale score measures: fear of long term (FCQLong term), vision-
related (FCQVision), heart-related (FCQHeart), kidney related (FCQKidney), stroke-related 
(FCQStroke), peripheral vascular disease-related complications (FCQCirculation) and fear of 
complications from poorly controlled blood glucose levels (FCQBlood Glucose). The absolute 
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subscale and absolute composite scores were converted to percentage scores prior to 
statistical analysis. The FCQ vision subscale score (FCQVision) was used as a measure of 
concern for potential vision loss.  
 
Summary of Diabetes Self-Care Activities (SDSCA) Questionnaire: 
The Summary of Diabetes Self-Care Activities (SDSCA) is a brief, self-report questionnaire 
of diabetes self-management that includes items assessing the following aspects of the 
diabetes regimen over the previous 7 days: general diet, specific diet, exercise, blood-
glucose testing, foot care, medication compliance and smoking. A revised version of the 
questionnaire created by Toobert et al was used in this study (30). The measure is a 
reliable and valid and found to be useful for both research and practice. The absolute 
SDSCA subscale and composite scores were converted to percentage scores prior to 
statistical analysis. In this study the SDSCAComposite score was the primary score of interest 
and was used as a measure of overall self-care activities in diabetic patients.   
 
e. Statistical Analysis: 
All statistical analyses were performed using PASW Statistics 17 (SPSS). Data from the 
questionnaires was manually entered into the SPSS program.  
  
Pre-Study Power analysis:  
Effect size estimates were computed from four papers that describe either fear of vision 
loss alone or fear of overall diabetes complications, predictors of these fears and how they 
impact a number of outcome variables (15, 19, 29, 32).  Effect sizes were estimated per 
group i.e. Type 1 and Type 2 diabetic subjects. For an effect size (correlation coefficient r) 
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of 0.25 or greater, alpha of 0.05, and power of greater than 0.80, a total per group sample 
size of 98 is needed. This sample will also make it possible to determine a difference 
between two correlation coefficients of 0.30 or greater. Furthermore, a sample size of 98 
per group will allow for an effect size (i.e. difference in questionnaire scores between Type 
1 and Type 2 diabetic subjects) of 20 or greater. Given an anticipated drop-out rate of 
10%, the final total number of subjects needed for enrollment is 215.  
 
Population Comparisons:  
Chi-square analysis was used to compare nominal and ordinal characteristics between 
Type 1 and Type 2 diabetic subjects. Subjects with unknown diabetes status were not 
included in the Chi-square analysis because the majority of expected counts for variables 
studied in this group were less than 5.   Independent sample Student T-test was used to 
compare means of continuous variables (i.e. age, questionnaire scores) between Type 1 
diabetic and Type 2 diabetic subjects. Student T-test analysis was also used to compare 
VFQ, FCQ, SDSCA questionnaire scores between participants with and without diabetic 
retinopathy.  
 
Correlations: 
In order to decide which type of correlation analysis, the distribution of all questionnaire 
scores was analyzed using values of skewness and kurtosis. As most of the scores were 
not normally distributed, Spearman correlation analysis was used instead of Pearson 
correlation analysis.  The majority of SDSCA subscale and composite scores had a 
negatively skewed distribution. All the VFQ subscale and composite scores had negatively 
skewed distributions. The FCQ composite and subscale scores were either normally 
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distributed or positively skewed. Spearman correlation analysis was used to assess 
relationships between VFQ, FCQ, and SDSCA subscale and composite scores. This 
analysis was performed for Type 1 diabetics alone, Type 2 diabetics alone, unknown 
diabetics alone and all groups combined. Given the study aims and hypotheses, the 
statistical significance of the following correlations was of particular interest: 
1. Correlation between VFQItem 3 score and SDSCAComposite score 
2. Correlation between VFQ Mental Health score and SDSCAComposite  score 
3. Correlation between VFQComposite  score and SDSCAComposite  score 
4. Correlation between FCQVision score and SDSCAComposite score 
5. Correlation between FCQComposite score and SDSCAComposite  score 
 
Linear and Multiple Regression Analysis:  
Linear regression analysis was used to determine the relationship between the 
SDSCAComposite score as the dependent variable and VFQItem 3, VFQ Mental Health, 
VFQComposite, FCQVision, and FCQComposite, and scores as the independent variables.  This 
was performed for Type 1 diabetics alone, Type 2 diabetics alone, unknown diabetics 
alone and all groups combined. The only statistically significant relationship found was that 
between VFQItem 3 and SDSCAComposite scores. Multiple regression analysis was then 
performed with the other individual components of the VFQ mental health score (items 21, 
22, 25, and A12) held constant to assess their impact on the linear relationship between 
VFQItem 3 and the SDSCAComposite score. 
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Analysis of Confounding Factors using ANCOVA:  
ANCOVA was used to determine how controlling for potential confounding factors 
influenced the association between VFQItem 3 and SDSCAComposite scores in the Type 1 
diabetes group. The confounding factors of particular interest that were adjusted for 
individually and combined together in this analysis were: age, gender, employment, marital 
status, insurance, length of time with diabetes, medication type, history of diabetic 
retinopathy, history of laser treatment for diabetic retinopathy and presbyopia. The 
following eye-related parameters were also controlled for individually and simultaneously: 
diabetic retinopathy, myopia, presbyopia, macular degeneration, cataract, glaucoma, 
cataract surgery, laser therapy for diabetic retinopathy. Levene’s test for equality of 
variances was used to test the null hypothesis that the error variance of SDSCAComposite 
score was equal across all groups. In these analyses VFQ Item 3 was run as the covariate, 
the SDSCAComposite score as the dependent variable and the confounding variables as fixed 
factors. Effect sizes (ŋ2 and r) for the association between VFQItem 3 scores and 
SDSCAComposite scores were also generated.   
 
Assessing Relationship between Questionnaire Scores and HgA1c using ANOVA: 
ANOVA was used to determine the relationship between HgA1c levels and VFQItem3, 
VFQMental Health, VFQComposite,  FCQVision, and FCQComposite scores. Planned contrasts were 
used to compare mean questionnaire scores of participants in different HgA1c categories. 
This analysis was performed for Type 1 diabetics alone, Type 2 diabetics alone, unknown 
diabetics alone and all groups combined.  
 
 
15 
 
4. Results 
Population Comparisons: 
A total of 100 patients (24 Type 1, 69 Type 2, 7 Unknown) were examined.  Type 1 diabetic 
participants were younger (mean age 44.0yrs compared to 59.2yrs; p< 0.001) and more likely to be 
female (75.0%, 49.3%; χ2=4.78, p=0.029) than Type 2 diabetic participants. Type 1 diabetics were 
also more likely to be employed (50.0%, 34.8%; χ2=11.6, p=0.009), less likely to be disabled 
(8.30%, 18.3%; χ2=11.6, p=0.009) and less likely to be retired (8.30%, 34.8%; χ2=11.6, p=0.009) 
than their Type 2 diabetic counterparts.  Type 1 diabetic subjects were more likely to be single 
(45.5%, 20.3%; χ2=11.7, p=0.008) and have private (54.2%, 34.8%; χ2=14.2, p=0.047) and state 
(12.4%, 4.30%; χ2=14.2, p=0.047) insurance.  Not surprisingly, Type 1 diabetic participants had 
had diabetes for longer (greater than 20 years: 37.5%, 18.8%; χ2=27.0, p<0.001) and were also 
more likely to use insulin injections (58.2%, 29.0%; χ2=45, p<0.001) and have insulin pumps 
(37.5%, 0.00%; χ2=45.0, p<0.001) than their Type 2 counterparts.  Of particular note was the fact 
that Type 1 diabetic participants were significantly more likely to report diabetic retinopathy (62.5%, 
17.4%; χ2=17.6, p<0.001) and report past laser treatment for diabetic retinopathy (41.7%, 14.5%; 
χ2=7.79, p=0.005) than Type 2 participants. Type 1 participants were less likely to have presbyopia 
(54.2%, 76.8%; χ2=4.43, p=0.035) (Table 1a).  
 
There were no significant differences between Type 1 and Type 2 diabetic subjects in language 
most spoken at home, race, yearly income level or highest level of education. There was no 
significant difference in the distribution of HgA1c levels between the two groups. There was also no 
significant difference in smoking status, the incidence of myopia, cataract, cataract surgery, 
macular degeneration, glaucoma, and time of last eye examination or eye examination with 
dilatation between the two groups. Furthermore, there was no significant difference in the incidence 
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of diabetes-related kidney disease, stroke, heart disease, myocardial infarction, hypertension, 
peripheral vascular disease, or amputation between the two groups. Finally, there was no 
significant difference between the two groups with regards to family history of diabetes-associated 
kidney disease, diabetic retinopathy, stroke, blindness or amputation. 
 
With regards to questionnaire scores, there were significant differences between Type 1 and Type 
2 diabetic subjects in SDSCABlood Glucose Testing, SDSCAFoot Care, and SDSCA Composite scores. On 
average, Type 1 diabetics tested their blood glucose more regularly, took better care of their feet 
and had better overall self-care practices than their Type 2 diabetic counterparts (Table 1b). Tables 
1c – e show scores that are significantly different between patients with and without diabetic 
retinopathy for all groups combined, Type 1 diabetics alone and Type 2 diabetics alone. 
 
Correlations: 
Correlation between SDSCAComposite Score and VFQItem 3 /VFQMental Health Scores: 
For participants with Type 1 Diabetes, there was a statistically significant positive correlation 
between the SDSCAComposite score and the VFQItem 3 score (rSpearman=0.521, N=24, p=0.009) (Table 
2a). Therefore, decreased self-care behavior (↓SDSCAComposite score) was associated with greater 
concern for overall eyesight (↓ VFQItem 3) and vice versa.  There was also a statistically significant 
positive correlation between the SDSCAComposite score and the VFQMental Health score (r=0.413, N=24, 
p=0.045) (Table 2a). Therefore a decrease in level of self-care (↓SDSCAComposite) was associated 
with greater vision-related emotional distress (↓ VFQMental Health) and vice versa. Correlation 
analyses between SDSCAComposite score and the other four components of  the VFQMental Health score 
(i.e. vision-related frustration (VFQItem 21), dependence (VFQItem 22), embarrassment (VFQItem 25) and 
irritability (VFQItem A12)) were individually performed.   There were no significant correlations 
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between the afore-mentioned score components and the SDSCAComposite score (Table 2b). As 
such,   VFQItem 3 alone accounts for the statistical significance of the association between vision-
associated emotional distress (VFQMental Health) and self-care behavior (SDSCAComposite) (Table 2b).  
 
For patients with Type 2 diabetes, patients with unknown diabetes type, and all patients combined 
there were no statistically significant correlations between the SDSCAComposite score and VFQItem 3 
nor between the SDSCAComposite score and the  VFQMental Health score (Table 2c – e). Despite the 
non-significance of these correlations it is interesting to note that they were all negative for these 
subject groups (Table 2c – e), meaning that a decrease in self-care behavior (↓ SDSCAComposite ) 
was associated with less concern for overall eyesight (↑ VFQItem 3) and less vision-related 
emotional distress (↑ VFQMental Health)  .  
 
Correlation between SDSCAComposite Score and FCQVision / FCQComposite Scores: 
For Type 1, Type 2, Unknown and all groups combined there were no statistically significant 
correlations between the SDSCAComposite score and FCQVision score nor between the SDSCAComposite 
score and the FCQComposite score (Table 2a – e). As such, there was no significant association 
between self-care behavior and concern for potential vision loss or between self-care behavior and 
concern for overall potential diabetes complications.  Despite the lack of statistical significance of 
the association between SDSCAComposite and FCQVision, it is interesting to note that the correlation 
was negative in the Type 1 diabetes group (r = - 0.178,N=24, p =0.404), but positive in the Type 2 
(r=0.131, N= 69, p=0.285), and Unknown (r =0.182, N = 7, p = 0.696)  diabetes groups and all 
groups combined (r=0.08, N = 100, p = 0.381) .  The correlation between SDSCAComposite and 
FCQComposite, though lacking statistical significance, was negative in the Type 1 group (r = -0.359, 
N=24, p =0.085) and all groups combined (r = -0.035, N=100, p= 0.727) but positive in the Type 2 
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(r = 0.012, N=69, p=0.924) and unknown diabetic groups (r=0.144, N=7, p=0.75).  In this instance a 
negative correlation means that a decrease in self-care behavior (↓ SDSCAComposite) is associated 
with an increase in concern for potential vision loss/concern for overall diabetes complications (↑ 
FCQVision /FCQComposite) and vice versa , while a positive correlation means that a decrease in self-
care behavior (↓ SDSCAComposite) is associated with a decrease in concern for potential vision 
loss/concern for overall diabetes complications (↓ FCQVision/FCQComposite) and vice versa .  
 
Correlation between SDSCAComposite Score and VFQComposite Score: 
For Type 1, Type 2, Unknown and all groups combined there were no significant correlations 
between SDSCAComposite score and VFQComposite score (Table 2 a – e). Despite the non-significance 
of these correlations, it is interesting to note that for the  Type 1 diabetes group, Type 2 diabetes 
group, and  all groups combined the correlations had a trend towards being positive (Type 1: 
r=0.357, N=24, p=0.057; Type 2: r=0.022, N=69, p= 0.861; All patients: r = 0.082, N= 100, p = 
0.419), while for the Unknown diabetes group the correlation was negative (Unknown: r = -0.036, 
N=7, p= 0.939). In this instance a negative correlation means that a decrease in self-care behavior 
(↓ SDSCAComposite) is associated with an increase in vision-related quality of life (↑ VFQComposite) and 
vice versa , while a positive correlation means that a decrease in self-care behavior 
(↓SDSCAComposite) is associated with a decrease in vision-related quality of life (↓ VFQComposite) and 
vice versa . 
 
Linear and Multiple Regression Analysis 
 Linear regression analysis demonstrated that in Type 1 diabetic subjects the concern for overall 
eyesight component (VFQItem 3) of the VFQMental Health score significantly predicted self-care behavior 
(β=0.118,βs=0.481, p=0.017) (Table 3a). Furthermore, 23.1% of the variance in the SDSCAComposite 
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score was predicted by the VFQItem 3 score (Table 3a, Figure 1, 2). When the other individual 
components of the   VFQMental Health score (items 21, 22, 25, and A12) were included in the analysis 
(i.e. held constant), the strength of the relationship between VFQItem 3 and SDSCAComposite scores 
increased (β=0.155, βs=0.630, p=0.018) with this model accounting for 35.7% of the variance in 
SDSCAComposite score (Table 3b).   
 
Fear of other complications of diabetes (as measured by the FCQ subscale scores) was adjusted 
for using multiple regression analysis. The association between VFQItem 3 and SDSCAComposite score 
in the Type 1 diabetic group became statistically insignificant when fear of long-term complications 
(FCQLong-term), peripheral vascular disease (FCQCirculation) and fear of overall diabetes complications 
(FCQComposite) were individually adjusted for (Table 3b). Linear regression analysis showed no 
significant relationship between the VFQMental Health, VFQComposite, FCQVision and FCQComposite scores 
as the predictor variables and the SDSCAComposite score as the dependent variable in the Type 1 
diabetes group. 
 
ANCOVA: 
In the individual analysis of cofounding variables for the Type 1 diabetes group, the relationship 
between the VFQItem 3 scores and the SDSCAComposite scores remained statistic ally significant when 
all factors except for employment status (F= 2.973 (1,19), p=0.101, rVFQ Item 3 = 0.368) and diabetic 
retinopathy (F = 4.274 (1,21), p = 0.051, rVFQ Item 3 = 0.411) were controlled for (Table 4). However, 
the effect of employment is questionable given that the error variance of SDSCA scores across the 
employment groups is not equal. Furthermore, although having diabetic retinopathy was 
associated with lower SDSCAComposite scores than not having diabetic retinopathy, this association 
was not statistically significant (Table1c –d). The relationship between VFQItem 3 scores and 
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SDSCAComposite scores also become insignificant when all of the variables that differed significantly 
between Type 1 and Type 2 diabetic groups (i.e. age, gender, employment status, marital status, 
health insurance, years with diabetes, medication type, diabetic retinopathy, laser treatment, 
presbyopia) were included in the analysis. The relationship remained statistically significant when 
the other eye-related factors (macular degeneration, myopia, cataract, glaucoma, cataract surgery) 
were individually controlled for. Furthermore, with VFQItem 3 run as a covariate and diabetic 
retinopathy, myopia, presbyopia, macular degeneration, cataract, glaucoma, cataract surgery and 
laser treatment for diabetic retinopathy as fixed factors, the association between VFQItem 3 and 
SDSCAComposite score remained significant (F (1, 14) = 8.14, p = 0.013, rVFQ Item 3=0.500, B= 0.128) 
(Table 4a).   
 
ANOVA 
ANOVA was used to determine the effect of VFQItem 3, VFQMental Health score, VFQComposite score, 
FCQVision, FCQComposite and SDSCAComposite scores on HgA1c values. In the Type 2 Diabetes Group, 
There was a significant effect of HgA1c on all FCQ subscale scores except FCQCirculation (Table 5b). 
This effect had a significantly linear trend between HgA1c and all FCQ subscale scores (except 
FCQKidney and FCQ Circulation) such that as HgA1c levels increased, the respective FCQ subscale 
scores increased proportionately (Table 5b).  Planned contrasts showed that for any HgA1c level > 
5.9, there was an associated increase in FCQVision, FCQBlood Glucose, FCQComposite scores. 
Furthermore, compared to HgA1c levels ranging from 8.0 – 8.9, HgA1c levels greater than 9.0 
were associated with higher FCQComposite, FCQVision, FCQBlood Glucose, FCQLong Term, FCQStroke and 
FCQHeart scores.  Calculation of individual model effect sizes (ω) and contrast effect sizes (r) 
showed that the association between FCQVision and HgA1c had the third largest effect size, 
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preceded only by  the association between HgA1c and FCQComposite and FCQBlood Glucose 
scores respectively (Table 5b, 5c). 
 
For all groups combined, there was a significant effect of HgA1c on FCQComposite, FCQ Blood Glucose 
and FCQStroke scores (Table 5b). However, this effect was only significantly linear between HgA1c 
and all FCQBlood Glucose scores, such that as HgA1c levels increased, the FCQBlood Glucose score 
increased proportionately (Table 5b). Planned contrasts showed that compared to HgA1c levels 
ranging from 8.0 – 8.9, HgA1c levels >9.0 were associated with higher FCQComposite, FCQBlood Glucose 
and  FCQStroke scores. Calculation of individual model effect sizes (ω) and contrast effect sizes (r)  
demonstrated that the association between FCQBlood Glucose and HgA1c had the largest effect size, 
followed by  the association between HgA1c and FCQStroke and FCQ Composite scores respectively 
(Table 5b, 5c). 
 
 No significant effect between HgA1c and FCQ Composite and subscale score was found for the 
Type 1 diabetes group. Furthermore, for the Type 1 diabetes group, Type 2 diabetes group and all 
groups combined no statistically significant effects of HgA1c values on VFQItem 3,  VFQMental Health,  
and VFQComposite scores respectively were determined.  
 
5. Discussion 
Type 1 Diabetes Group 
This study has demonstrated that in Type 1 diabetics, self-care behavior (SDSCAComposite) is 
negatively correlated with concern for overall eyesight (VFQItem 3) but not significantly associated 
with concern for potential vision loss (FCQVision). The correlation between self-care behavior and 
concern for overall eyesight becomes statistically insignificant when diabetic retinopathy and 
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employment status are individually adjusted for, and when demographic variables that differ 
significantly between the Type 1 and Type 2 diabetic groups are controlled for simultaneously.  
Furthermore, individually adjusting for fear of overall complications (FCQComposite), long-term 
complications (FCQLong-term) and peripheral vascular disease (FCQCirculation) causes the linear 
relationship between concern for overall eyesight and self-care behavior to become statistically 
insignificant. Linear regression analysis confirms the correlation between concern for overall 
eyesight as a predictor variable and self-management behavior as the dependent variable, 
however causality cannot be proved from these results. It is therefore possible that concern for 
overall eyesight, either because of current subjective vision loss or future potential vision loss, 
generates  a mentality in Type 1 diabetic patients that results in poorer self-care behavior. 
However, it is more plausible that Type 1 diabetics with poor self-care behavior are simply more 
concerned about overall  eyesight because of their awareness of the consequences of inadequate 
self-management practices, or because they already have diabetes-related eye disease that they 
know can be worsened by their poor self-care behavior.   
 
In the Type 1 diabetes group, there were no statistically significant relationships between concern 
for overall diabetes complications (FCQComposite) and self-care behavior (SDSCAComposite), or 
between HgA1c values and self-care behavior (SDSCAComposite), concern for  overall eyesight 
(VFQItem 3), vision-associated emotional distress (VFQMental Health ) and concern for overall diabetes 
complications (FCQComposite) respectively. Although there was a negative correlation between self-
care behavior and vision-associated emotional distress (VFQMental Health) in the Type 1 diabetes 
group, concern for overall eyesight (VFQItem 3) was the only one of the five components of the 
VFQMental Health score that significantly contributed to this correlation; the other four components of 
the VFQMental Health score did not individually contribute in a statistically significant manner to this 
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correlation (Table 2a). As such, the VFQMental Health score can essentially be equated to the VFQItem 3 
score when describing the relationship between SDSCAComposite and VFQMental Health. 
 
Given the absence of a statistically significant relationship between concern for potential vision loss 
(FCQVision) and self-care behavior (SDSCAComposite), it is possible that there are elements of concern 
for overall eyesight (VFQItem 3) that are not measured by the FCQVision score but are associated with 
self-care behavior.  This is supported by the observation that although FCQVision and VFQItem 3 are 
positively correlated (Table 2b), the correlation coefficient is less than 1. Since FCQVision measures 
concern for potential vision loss, one can speculate that concern for current subjective vision loss 
accounts for a significant proportion of the relationship between concern for overall eyesight 
(VFQItem 3) and self-care behavior in the Type 1 diabetes group.  It would not be surprising if this 
were indeed the case,  since  62.5% of subjects in the Type 1 diabetes group reported having the 
diagnosis of diabetic retinopathy(Table 1a), and are as such more likely to be concerned about 
current subjective vision loss than they are about potential future vision loss.   
 
The validity of the effect of employment on the relationship between self-care behavior and 
concern for overall eyesight is questionable, particularly since the error variance of SDSCAComposite 
scores across the employment categories is not equal. Nonetheless, further analysis of the data 
shows that both employed and unemployed members of the Type 1 diabetes group have 
significantly better self-care behavior than their disabled counterparts. ‘Disabled’ in this context 
refers to participants on social security disability insurance who are unable to work because of 
medical conditions spanning all organ systems. Selby et al (33)  have demonstrated that lower 
income and lower general health status are associated with poor self-care behavior and poorly 
controlled diabetes (i.e. HgA1c >8%, systolic blood pressure > 140 mmHg and LDL-cholesterol > 
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130 mg/dL). It is therefore conceivable that subjects who are employed have greater financial 
resources and fewer physical impediments than their disabled counterparts, thereby enabling them 
to better adhere to self-management practices. The same can be said for unemployed subjects 
who may not be as well equipped financially as their employed counterparts, but are more likely to 
be physically able to comply with self-care activities than their disabled counterparts. Employment 
status presumably accounts for a substantial proportion of the self-care behavior of Type 1 
subjects in this study such that adjusting for it minimizes the observed interaction between concern 
for  overall eyesight and self-management behavior and makes the association statistically 
insignificant.   
 
To further understand the impact of diabetic retinopathy on the relationship between self-care 
behavior and concern for overall eyesight, it is interesting to note that the presence of diabetic 
retinopathy is associated with lower SDSCAComposite scores (i.e. poorer self-care behavior) in the 
Type 1 diabetic group though not in a statistically significant manner (Table 1d). Furthermore, 
diabetic retinopathy is associated with lower VFQMental Health scores (i.e. greater concern for overall 
eyesight) in a statistically significant manner among Type 1 diabetic participants (Table 1d). Klein 
et al (15) have shown a statistically significant correlation between severity of diabetic retinopathy 
and concern for overall eyesight (as measured using the VFQMental Health score): less severe diabetic 
retinopathy was associated with less concern for overall eyesight while more severe diabetic 
retinopathy was associated with greater concern for overall eyesight.   Given the relationship 
between diabetic retinopathy and concern for overall eyesight in the Klein study as well as the 
potential association between diabetic retinopathy and self-care behavior in this study, it is very 
probable that the relationship between concern for overall eyesight and self-care behavior is 
substantially attributable to the presence of diabetic retinopathy in Type 1 diabetics.  This is further 
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supported by the fact that adjusting for other eye-related factors (i.e. macular degeneration, 
myopia, presbyopia, cataract, glaucoma, cataract surgery, laser therapy) had no effect on the 
statistical significance of the relationship between concern for overall eyesight and self-care 
activities.  A larger sample size may however be required to prove the statistical significance of the 
association between diabetic retinopathy and self-care behavior to further support this explanation.  
 
In this study no significant correlation between concern for overall diabetes complications 
(FCQComposite) and self-care behavior (SDSCAComposite) nor between concern for potential vision loss 
(FCQVision) and self-care behavior were demonstrated in the Type 1 diabetes group. As such it is 
not possible to determine what proportion of the correlation between concern for overall diabetes 
complications and diabetes self-care behavior is accounted for by concern for overall eyesight  or 
concern for potential vision loss in Type 1 diabetic participants. Nonetheless the individual effects 
of concern for overall, long-term and peripheral vascular complications (FCQComposite, FCQLong-term, 
and FCQCirculation scores respectively) on the significance of the linear relationship between concern 
for overall eyesight (VFQItem 3) and self-care behavior (SDSCAComposite) ,suggest that these 
concerns contribute in such a way as to make the negative relationship between self-care behavior 
and concern for overall eyesight statistically insignificant. For instance, it is possible that better self-
care behavior is associated with greater concern for the afore-mentioned categories of 
complications therefore canceling out the effect of self-care behavior on concern for overall 
eyesight.  The associations between self-care behavior and concern for overall diabetes 
complications and between self-care behavior and concern for potential vision loss respectively 
may be better evaluated in a larger sample population of Type 1 diabetic participants. 
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There is evidence in the literature to suggest that diabetic patients with deteriorated vision develop 
an increased awareness of the need for good glycemic control and the risks of other diabetic 
complications (27).  As has been demonstrated in the literature, one would expect increased 
awareness or education about diabetes complications and management to result in an 
improvement in self-care behavior and glycemic control (34-37). However, in this study, there is no 
statistically significant difference in SDSCAComposite score between Type1 diabetic patients with and 
without diabetic retinopathy (Table 1d). This  discrepancy therefore suggests that  there are 
elements associated with having diabetic retinopathy that prevent our study population of Type 1 
diabetics from taking better care of themselves.  In this study, Type 1 diabetic subjects with 
diabetic retinopathy had a longer duration of diabetes than their counterparts without diabetic 
retinopathy (73.3% reported 20 or greater years of diabetes compared to 44.4% of subjects without 
diabetic retinopathy). Both Eiser et al and Shah et al have demonstrated that diabetic patients with 
longer disease duration are more reluctant to change their self-management practices ((38, 39).  
As such, it is possible that despite the likely increase in awareness of diabetes complications 
among subjects with diabetes-associated vision loss, resistance to change yields poor self-care 
behavior I this population.  
 
Although the primary hypotheses of this study did not specify the expected direction of the 
relationship between concern for overall eyesight and self-care behavior, the negative correlation 
between these two variables highlights a significant discrepancy between patients’ health-related 
beliefs and behaviors regardless of the direction of the relationship.   If poorer self-care behavior 
predicts greater concern for overall eyesight, then patients’ concern for overall eyesight most likely 
arises from awareness of the consequences of their poor self-care practices. If on the other hand, 
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greater concern for overall eyesight predicts poorer self-care behavior, disempowering attitudes 
towards self management, such as decreased sense of self-efficacy (i.e. perceived capability to 
change behavior) and anxiety may be at play.  In this age of rising prevalence of chronic disease, 
there has been a concomitant response in the redesign of primary care systems to improve 
management and outcomes of long-term illness(40-45).  Motivational interviewing has come to the 
forefront as an effective way of helping health systems (at the clinician-patient level) deliver 
integrated chronic disease care while empowering patients to effectively self-manage their long-
term diseases (45).  
 
Motivational interviewing is a ‘client centered directive method of enhancing intrinsic motivation to 
change by exploring and resolving ambivalence’ (46). The principles of the motivational 
interviewing approach are captured by the alliterations: Express Empathy; Develop Discrepancy; 
Roll with Resistance; Support Self Efficacy, and the acronym R.U.L.E: Resist the righting reflex; 
Understanding your patient’s dilemma and motivations; Listen to and Empower your patients (46, 
47).  Motivational interviewing is currently utilized by clinicians to successfully improve patient 
outcomes in a wide range of settings including diabetes management. For instance, in teenagers 
with Type 1 diabetes, motivational interviewing was shown in a multicenter randomized controlled 
trial by Channon et al to result in lower HgA1c levels as well as better psychosocial measures (e.g. 
more positive well-being and improved quality of life) than their counterparts who received support 
visits (48). In patients with newly diagnosed Type 2 diabetes, Brug et al found a significant 
reduction in saturated fat intake and increase in fruit intake among patients of dieticians trained in 
motivational interviewing (49).  
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Motivational interviewing could be used to effectively address the ambivalence identified in this 
study between participants’ concern for overall eyesight and self-care behavior.    The presence of 
such ambivalence suggests that there are factors in the lives of these Type 1 diabetic patients that 
have (from the perspective of the participants) a more compelling risk-benefit ratio than the self-
management practices that could improve their disease profile. For instance, one might imagine a 
Type 1 diabetic subject voicing ambivalence in the following way: ‘I want to control my diabetes to 
prevent (further) damage to my eyes. However if I exercise I am more likely to become 
hypoglycemic.’ or ‘I want to control my diabetes to prevent (further) damage to my eyes. However, 
cooking healthy meals takes up time that I could use watching television.’ Motivational interviewing 
could be used by all level clinicians (physicians, nurses, ophthalmologists etc) to help Type 1 
diabetics unearth such ambivalence and create avenues for patients’ active participation in finding 
practical ways of resolving this ambivalence and improving self-care behavior.  
 
Type 2 Diabetes Group 
ANOVA analysis demonstrated positive linear associations between HgA1c levels and concern for 
overall diabetes complications (FCQComposite), concern for potential vision loss (FCQVision), concern 
for complications from poorly controlled blood glucose (FCQBlood Glucose), concern for long-term 
diabetes complications (FCQLong Term), concern for heart disease (FCQHeart), and concern for stroke 
(FCQStroke) respectively in the Type 2 diabetes group.  Based on effect size calculations, concern 
for potential vision loss (FCQVision) was the second most likely specific concern to be associated 
with HgA1c levels; concern for complications from poorly controlled blood glucose levels (FCQBlood 
Glucose) was the most likely specific to be associated with HgA1c levels. There was no statistically 
significant association between concern for overall eyesight (VFQItem 3) and HgA1c levels. 
Furthermore, in the Type 2 diabetes group, there were no statistically significant associations 
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between self-care behavior (SDSCAComposite) and concern for overall eyesight (VFQItem 3), self-care 
behavior and concern for potential vision loss (FCQVision), or self-care behavior and concern for 
overall diabetes complications (FCQComposite).  In this instance also, it is not possible to prove 
causality. As such participants with high HgA1c scores could be more concerned about potential 
vision loss, overall diabetes complications or other specific complications because of their 
awareness of the consequences of poorly controlled glucose levels. Though less plausible, it is 
also possible that participants with high levels of concern about potential vision loss, overall 
diabetes complications or other specific complications have poorly controlled glucose levels 
because of high stress or anxiety or poor self-care behavior resulting from high stress or anxiety.  
 
Despite the association between concern for potential vision loss and HgA1c and between concern 
for overall diabetes complications and HgA1c, there was no statistically significant relationship 
between self-care behavior and HgA1c. As in other studies in the literature (34-37) , one would 
have expected self-care behavior to positively correlate with glycemic control.  It is likely that in this 
study where HgA1c was categorized and not measured as a continuous variable, statistical 
analysis performed to determine the relationship between self-care behavior and glycemic control 
was  less reliable. It is also conceivable that better glycemic control is associated more with 
interventions that occur in the clinic setting (e.g. medication changes to improve hyperglycemia) 
than with the participants’ own self-management practices.  Furthermore, this is a study in which 
self-care behavior was assessed by participants’ self-reported perception of their health behavior. 
As such varying levels of awareness of best self-care practices may have caused participants to 
both over- and under-estimate the degree to which they were in fact managing their own health. 
The balancing out effect of educational awareness on self-care trends may explain the absence of 
a statistically significant relationship between self-care behavior and HgA1c. Finally, although 
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current research suggests that the strength and direction of the relationship between stress and blood 
glucose control varies considerably between individuals (50, 51),  there is evidence to suggest that 
recent severe stressors are associated with poorer glycemic control (52) and that stress 
management training can improve glycemic control (53). It is therefore possible that increased fear 
of overall diabetes complications induces a stress response that perpetuates poorly controlled 
blood glucose levels and worse HgA1c values therefore decreasing the impact of adherence to 
self-care practices.  
 
Looking at the results obtained in this study, it is possible to say that Type 1 diabetics are 
concerned about overall eyesight because of poor self-care behavior and high incidence of diabetic 
retinopathy, while Type 2 diabetics are concerned about potential vision loss and overall diabetes 
complications because of their awareness of poor glycemic control.   If better self-care behavior 
does indeed predict good glycemic control, it can be inferred for the Type 2 diabetes group that 
poorer self-management behavior is associated with increased concern for vision loss and overall 
diabetes complications. Given this potential incongruence between health care beliefs and 
behavior, motivational interviewing could also be effectively used to increase Type 2 diabetic 
patient involvement in self-management practices.  
 
All Groups Combined 
In this study, there were no statistically significant relationships between concern for overall 
eyesight, concern for potential vision loss and self-care behavior or glycemic control (HgA1c) for all 
groups combined.  The statistically significant associations demonstrated between HgA1c and 
FCQComposite, FCQBlood Glucose and FCQStroke scores respectively are most likely the result of 
combining the associations seen in the Type 1 and Type 2 diabetic groups alone. 
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Study Limitations: 
This study has a number of limitations. The predicted sample size for this study was 215. However, 
only 100 subjects were enrolled.  This discrepancy is primarily due to the fact that after one month 
of recruiting participants for this study at the Yale Diabetes Center, the proportion of patients 
presenting to the clinic who had already completed the study increased substantially. With a less 
than optimum sample size, it is not possible to conclude with confidence that the study yielded all 
the statistically significant results that it had the potential for.  Furthermore, given the numerous 
statistically significant demographic and health-related differences between the Type 1 and Type 2 
diabetes groups, there were many potential sources of confounding.  However, the small sample 
size made it difficult to control for different combinations of all the potential confounding variables 
without decreasing the power of the study. As such only individual adjustments for confounding 
variables on the relationship between concern for vision loss and self-management behavior were 
considered as truly reliable.  A larger sample size would make it possible to control for different 
combinations of the confounding variables to further unveil any synergistic effects they may have 
on the outcomes of interest in this study. 
 
All the participants surveyed were patients at the Yale Diabetes Center.  Patients who are cared for 
in a diabetes clinic are not necessarily representative of the broad spectrum of diabetes patients. 
This sampling framework may therefore reduce the generalizability of the results obtained.  
According to 2004 to 2006 national survey data for people ages 20 years or older, 6.6 percent of 
non-Hispanic whites, 7.5 percent of Asian Americans, 10.4 percent of Hispanics, and 11.8 percent 
of non-Hispanic blacks had diagnosed diabetes (54). In New Haven County 69.9% of the 
population is non-Hispanic White, 13.0% is black, 13.3% is Hispanic and 3.5% is Asian (55). 
Inferring from this data, one would expect the racial distribution among diabetic patients attending 
32 
 
the Yale Diabetes Clinic to be as follows: 60% non-Hispanic white, 19% black, 18% Hispanic, and 
4% Asian. The population sample in this study therefore has a greater representation of whites 
(63%) and blacks (21%) and a smaller representation of Hispanics (10%) and Asians (2%) than 
expected.  Furthermore, since care of diabetic patients occurs in diverse contexts, participants 
could have also been recruited from general practices, community centers etc to allow for better 
representation as well as comparison of various diabetes care contexts.   Finally, a control group of 
non-diabetic subjects was not utilized in this study. The presence of a non-diabetic control group 
would have allowed for comparison of health beliefs and behaviors between members of the 
general population and diabetic subjects.   
 
All questionnaires in this study were interviewer-administered. To allow for more accurate 
answering of questionnaires, it may have been better to a give participants the opportunity to 
complete the questionnaires on their own. This is particularly pertinent to the SDSCA questionnaire 
- a measure of self-care behavior over the previous 7 days. The predominantly negative skew of 
the SDSCA composite and sub-scale score distributions could be due to participants’ desire to 
please the interviewer. The fact that a 100% medication compliance rate was measured among all 
100 subjects further highlights the way in which this ‘desire to please the interviewer’ could have 
influenced the responses to interviewer-administered questionnaires.  Furthermore, although the 
format for administering the questionnaires was standardized, the likelihood of interviewer bias is 
high particularly since the interviewer was also responsible for analyzing the data collected. 
 
Baseline mental health conditions were neither measured nor adjusted for in this study. ‘Concern’ 
for overall eyesight and ‘fear’ of overall and specific diabetes complications are multi-faceted 
psychosocial constructs. Mental health states such as depression and anxiety could therefore have 
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influenced the way in which participants answered the afore-mentioned questionnaires. For 
instance, participants with greater baseline anxiety may have exhibited greater concern for overall 
eyesight and fear of diabetes complications. Furthermore, there is evidence in the literature 
demonstrating that greater severity of depression symptoms is associated with poorer diet and 
medication regimen adherence and functional impairment in diabetic patients (56). As such mental 
health states such as depression could also have affected the way in which participants answered 
the SDSCA questionnaire. Anxiety and depression could have been measured using 
questionnaires such as the Hospital Anxiety and Depression (HAD) scale (57), and adjusted for 
accordingly in the study analyses.  
 
In this study, all health information including HgA1c values within the previous 3 months was 
determined from participants’ reports and was therefore subject to substantial recall error. To 
standardize and increase the accuracy of the process of acquiring HgA1c data, participants’ HgA1c 
could have been tested at the time of completion of the questionnaires using an instant, point-of-
care HgA1c measuring instrument. This method would have yielded continuous HgA1c values that 
could have then been easily used in correlation and regression analysis to obtain more reliable 
results. Along the same lines, information such as diabetes type, as well as the presence and 
severity of eye ailments (e.g. diabetic retinopathy, glaucoma, cataract etc) could have been 
confirmed either by examination of the participants or chart review. By depending on participants 
for provision of health information, one assumes that they are actively involved in and 
knowledgeable about their health when this may not necessarily be the case.  
 
Visual acuity of participants was not determined in this study. Nonetheless, the VFQComposite score 
has been shown to be significantly correlated with visual acuity such that higher scores are 
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associated with better visual acuity (15).  In this study, independent sample T-test analysis showed 
no significant differences in VFQComposite scores between Type 1 and Type 2 diabetes groups 
thereby suggesting that there were no significant differences in visual acuity.  However, given the 
multi-faceted nature of the VFQComposite score, it was not in fact used in this study as a measure of 
visual acuity.  To better isolate the effect of visual acuity on the relationship between concern for 
vision loss and self-care behavior, a direct and objective measure of visual acuity would have been 
more effective. 
 
Although the educational level of participants was accounted for in this study, knowledge of 
diabetes was not specifically measured.  According to a study by Osborn et al, having more 
knowledge about diabetes independently and directly predicted better self-care behavior; better 
self-care behavior predicted improved glycemic control (58).  Given the afore-mentioned findings, it 
is conceivable that participants’ level of diabetes knowledge is a factor that needs to be controlled 
for in order to better evaluate the relationship between concern for vision loss and self-care 
behavior. This is especially important since prior studies have shown that only a small proportion of 
diabetic patients are actually aware of diabetic retinopathy as a complication of diabetes (25, 26) – 
a fact that further begs the question of whether patients can be concerned about vision loss when 
they are not aware of the problem of diabetic eye disease.  Validated measures of diabetes 
knowledge include the Diabetes Knowledge (DKN) Scale (59)  and the 24-item Diabetes 
Knowledge questionnaire (60), either of which could have been included in the questionnaire 
packet utilized in this study. 
 
One of the goals of this study was to test the hypothesis that a significant proportion of the 
correlation between concern for overall complications and diabetes self-care activities/ glycemic 
35 
 
control is accounted for by concern for overall eyesight/potential vision loss in diabetic subjects.  
However, the measures for concern for overall eyesight (VFQItem 3) and concern for overall diabetes 
complications (FCQComposite) were derived from two distinct and separately validated 
questionnaires. As such,  had there been statistically significant correlations between self-care 
behavior and concern for vision loss and self-care behavior and concern for overall diabetes 
complications respectively, it would not have been possible to accurately determine what 
proportion of the latter correlation was accounted for by the former. To make the comparison 
plausible, the measure of concern for vision loss would have ideally been a subscale score of a 
questionnaire measuring overall concern for diabetes complications. For the Type 2 diabetic group 
in which statistically significant relationships were demonstrated between FCQVision and HgA1c and 
FCQComposite and HgA1c in the Type 2 diabetes group, the effect sizes are a useful way of 
comparing the strength of the associations between FCQ subscale scores and HgA1c but not for 
determining the proportion of the relationship between FCQComposite and HgA1c that they 
account for.  Although FCQ subscale scores were calculated in this study, the FCQ was not 
designed to have these subscale scores and as such is not be the most appropriate questionnaire 
for determining the proportion of the correlation between concern for overall complications and 
diabetes self-care activities that is accounted for by concern for vision loss.  A more suitable study 
instrument would therefore have to be designed and validated for this purpose. 
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6. Conclusions 
Poorer self-care behavior is associated with greater concern for overall eyesight and vice versa in 
Type 1 diabetics. Adjusting for diabetic retinopathy and employment status individually affect the 
statistical significance of this relationship. The incongruence between health care attitudes 
(concern for overall eyesight) and behaviors (diabetes self-care activities) can be targeted by 
health care providers using interventions such as Motivational Interviewing to promote active 
participation of this diabetic population in finding practical ways of resolving this ambivalence and 
improving self-care behavior. In Type 2 diabetic subjects, higher HgA1c levels are associated with 
increased concern for potential vision loss and increased concern for overall diabetes 
complications and vice versa.  However, there is no statistically significant relationship between 
self-care behavior and glycemic control.  Future studies to better understand the factors driving the 
afore-mentioned associations could result in the creation of new models of care or support the 
implementation of already existing models of care for better health outcomes in the diabetic 
population. 
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7. Tables 
 
Table 1a. Population Comparisons - Chi-Square Analysis of Demographic Characteristics of Type 1 and 
Type 2 Diabetes Groups. 
Type 1 DM Type 2 DM Chi Square (χ2) Significance  
(2-tailed)# 
Gender    4.78 0.029 
Female 18 (75.0%) 34 (49.3%)   
Male 6 (25.0%) 35 (50.7%)   
Employment Status   11.7 0.009 
Employed 12 (50.0%) 24 (34.8%)   
Unemployed  8  (33.3%) 8  (11.6%)   
Disabled 2  (8.30%) 13 (18.8%)   
Retired 2  (8.30%) 24 (34.8%)   
Marital Status   11.7 0.008 
Single 11 (45.8%) 14 (20.3%)   
Married 13 (54.2%) 34 (49.3%)   
Divorced 0 (0.00%) 14 (20.3%)   
Other 0 (0.00%) 7 (10.1%)   
Health Insurance   14.2 0.047 
Medicare Only 1 (4.2%) 11 (15.9%)   
Medicaid Only 2 (8.30%) 13 (18.8%)   
Private Only 13 (54.2%) 24  (34.8%)   
Medicare and 
Medicaid 
1 (4.20%) 3 (4.30%)   
Medicare and Private 2 (8.30%) 14 (20.30%)   
Medicaid and Private 2 (8.30) 0 (0.00%)   
Federal/State 3 (12.5%) 3 (4.30%)   
None 0 (0.00%) 1 (1.40%)   
Years with DM   16.1 <0.001 
Less than 20 years 9 (37.5%) 56 (81.2%)   
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#Only statistically significant distribution differences are here reported 
 
Table 1b.  Population Comparisons  -  Differences in Questionnaire Scores Between Participants with Type 
1 and Type 2 Diabetes 
 
Variable Type 1 DM  Type 2 DM T-test value Significance  
(2- tailed)# 
Age (yrs) 44.0 (±14.2) 59.2 (± 13.2) -4.76 <0.001 
SDSCA blood sugar testing (%) 97.0 (± 8.66) 80.1 (±30.5) 4.10 <0.001 
SDSCA foot care (%) 85.7 (±18.0) 71.1 (± 31.6) 2.76 0.007 
SDSCA Composite (%) 78.1 (±9.50) 70.2 (±17.4) 2.84 0.006 
 
#Only statistically significant differences in scores are here reported. 
 
 
Great than 20 years 15 (62.5%) 13 (18.8%)   
Medication Type   45.0 <0.001 
Pills/Tablets 0 (0.00%) 22 (31.9%)   
Insulin (Injection) 14 (58.3%) 20 (29.0%)   
Insulin (Pump) 9 (37.5%) 0 (0.00%)   
Pills/Tablets and 
Insulin 
1 (4.20%) 24 (34.8%)   
None 0 (0.00%) 3 (4.30%)   
Diabetic 
Retinopathy 
  17.6 <0.001 
Yes 15 (62.5%) 12 (17.4%)   
No 9 (37.5%) 57 (82.6%)   
Laser Treatment   7.79 0.005 
Yes 10 (41.7%) 10 (14.5%)   
No 14 (58.3%) 59 (85.5%)   
Presbyopia   4.43 0.035 
Yes 13 (54.2%) 53 (76.8%)   
No 11 (45.8%) 16 (23.2%)   
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Table 1c. Differences in Questionnaire Scores Between Participants with and without Diabetic Retinopathy 
(All Groups Combined) 
 
Variable (± SD) 
Diabetic Retinopathy 
(Yes) 
Diabetic Retinopathy 
(No) 
T-test 
value 
Significance 
 (2-tailed) 
FCQLong term  66.3 ± 28.0 51.8 ± 29.3 2.22 0.028* 
FCQVision 54.3 ± 34.5 36.5 ± 31.6 2.44 0.017* 
FCQKidney 44.0 ± 33.7 27.2 ± 32.1 2.29 0.024* 
FCQComposite 52.6 ± 25.2 41.9 ± 26.0 1.84 0.068 
SDSCABlood Glucose 95.0 ± 13.4 81.4 ± 29.9 3.12 0.002* 
SDSCAFoot Care 85.7 ± 19.3 71.9 ± 31.2 2.64 0.010* 
SDSCAComposite 74.2 ± 10.6 71.4 ± 17.5 0.785 0.434 
VFQGeneral Vision 66.7 ± 24.8 80.0 ± 14.9 -2.62 0.013* 
VFQNearActivities 76.9 ± 28.6 90.9 ± 16.3 -2.40 0.022* 
VFQDistant Activities 77.2 ± 28.1 92.4 ± 11.5 -2.74 0.010* 
VFQMental Health 76.3 ± 28.5 90.3 ± 9.87 -2.51 0.018* 
VFQRole Difficulties 78.2 ± 33.4 92.3 ± 18.1 -2.08 0.046* 
VFQDependency 82.7 ± 29.4 98.3 ± 7.47 -2.72 0.011* 
VFQColor Vision 85.2 ± 24.3 97.6 ± 12.6 -2.53 0.016* 
VFQComposite 79.8 ± 23.3 91.8 ± 8.51 -2.63 0.014* 
VFQItem 3 47.2 ± 38.8 62.3 ± 30.1 -2.06 0.042* 
VFQItem 21 76.9 ± 38.6 96.2 ± 15.4 -2.54 0.012* 
VFQItem 22 77.8 ± 37.6 95.5 ± 14.6 -2.39 0.023* 
VFQItem 25 87.0 ± 28.1 99.7 ± 2.93 -2.33 0.028* 
 
*Statistically significant difference in scores between diabetic subjects with and without diabetic retinopathy 
(all groups combined)  
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Table 1d. Differences in Questionnaire Scores Between Participants with and without Diabetic Retinopathy 
(Type 1 Diabetes Group only) 
 
* Statistically significant differences in scores between diabetic subjects with and without diabetic retinopathy 
(Type 1 diabetes group). 
 
 
Table 1e. Differences in Questionnaire Scores Between Participants with and without Diabetic Retinopathy 
(Type 2 Diabetes Group only) 
 
Variable 
Diabetic Retinopathy 
(Yes) 
Diabetic Retinopathy 
(No) 
T-test 
value 
Significance  
(2-tailed)# 
FCQKidney 48.1±38.9 26.3±32.2 2.06 0.044 
SDSCAFoot Care 85.7±19.0 68.0±33.0 2.52 0.018 
 
#Only statistically significant differences in scores are here reported. 
 
 
Variable (± SD) 
Diabetic Retinopathy 
(Yes) 
Diabetic Retinopathy 
(No) 
T-test 
value 
Significance  
(2-tailed) 
FCQVision 54.4±31.2 25.9±22.2 2.40 0.026* 
SDSCAExercise 99.0±3.70 93.7±13.1 -3.26 0.004* 
SDSCAComposite 75.7 ±8.72 82.3 ±8.78 -1.79 0.087 
VFQDistant Activities 76.1±30.5 95.4±11.1 -2.21 0.039* 
VFQRole Difficulties 77.5±33.1 100.0±0.0 -2.63 0.02* 
VFQMental Health 74.0±28.1 93.3±6.1 -2.57 0.021* 
VFQDependency 81.1±30.6 100.0±0.0 -2.39 0.031 
VFQDriving 72.2±33.8 98.3±3.7 -2.64 0.022* 
VFQColor Vision 86.7±20.8 100.0±0.0 -2.48 0.027* 
VFQPeripheral Vision 80.0±33.0 100.0±0.0 -2.35 0.034* 
VFQComposite 79.6±23.7 96.6±3.0 -2.74 0.015* 
VFQItem 3 41.7±38.6 66.7±30.6 -1.65 0.113 
VFQItem 21 75.0±40.1 100.0±0.0 -2.42 0.030* 
VFQItem 22 75.0±40.1 100.0±0.0 -2.42 0.030* 
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Table 2a. Significant and non-significant Spearman Correlations of Interest for the Type 1 Diabetic Group 
(N= 24) 
 
Spearman's rho SDSCA 
Composite 
score VFQ Item 3 
VFQ 
Mental 
Health 
Score 
VFQ 
Composite 
Score 
FCQ 
Vision 
Score 
FCQ 
Composite 
Score  
SDSCA 
Composite 
score 
Correlation 
Coefficient 
1.000 .521** .413* 0.393 -0.178 -0.359 
Sig. (2-
tailed) 
. 0.009 0.045 0.057 0.404 0.085 
VFQ Item 3 Correlation 
Coefficient 
.521** 1.000 .967** .610** -.483* -.556** 
Sig. (2-
tailed) 
0.009 . 0.000 0.002 0.017 0.005 
VFQ 
Mental 
Health 
Score 
Correlation 
Coefficient 
.413* .967** 1.000 .682** -.530** -.550** 
Sig. (2-
tailed) 
0.045 0.000 . 0.000 0.008 0.005 
VFQ 
Composite 
Score 
Correlation 
Coefficient 
0.393 .610** .682** 1.000 -0.274 -0.356 
Sig. (2-
tailed) 
0.057 0.002 0.000 . 0.195 0.088 
FCQ 
Vision 
Score 
Correlation 
Coefficient 
-0.178 -.483* -.530** -0.274 1.000 .679** 
Sig. (2-
tailed) 
0.404 0.017 0.008 0.195 . 0.000 
FCQ 
Composite 
Score  
Correlation 
Coefficient 
-0.359 -.556** -.550** -0.356 .679** 1.000 
Sig. (2-
tailed) 
0.085 0.005 0.005 0.088 0.000 . 
 
 
* Correlation is significant at the 0.05 level (2-tailed). 
**Correlation is significant at the 0.01 level (2-tailed). 
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Table 2b.  Spearman Correlation between VFQMental Health Score components and SDSCAComposite Score in the 
Type 1 Diabetes Group (N = 24). 
 
Spearman's rho SDSCA 
Composite 
Score VFQItem 3  VFQItem 21 VFQItem 22 VFQItem 25 VFQItem A12 
VFQ Mental 
Health 
Score 
SDSCA 
Composite 
Score 
Correlation 
Coefficient 
1.000 .521** 0.025 0.020 0.066 -0.110 .413* 
Sig. (2-
tailed) 
. 0.009 0.908 0.926 0.758 0.609 0.045 
VFQItem 3  Correlation 
Coefficient 
.521** 1.000 .565** .565** .472* 0.363 .967** 
Sig. (2-
tailed) 
0.009 . 0.004 0.004 0.020 0.082 0.000 
VFQItem 21 Correlation 
Coefficient 
0.025 .565** 1.000 .993** .829** .703** .716** 
Sig. (2-
tailed) 
0.908 0.004 . 0.000 0.000 0.000 0.000 
VFQItem 22 Correlation 
Coefficient 
0.020 .565** .993** 1.000 .835** .710** .719** 
Sig. (2-
tailed) 
0.926 0.004 0.000 . 0.000 0.000 0.000 
VFQItem 25 Correlation 
Coefficient 
0.066 .472* .829** .835** 1.000 .816** .646** 
Sig. (2-
tailed) 
0.758 0.020 0.000 0.000 . 0.000 0.001 
VFQItem A12 Correlation 
Coefficient 
-0.110 0.363 .703** .710** .816** 1.000 .551** 
Sig. (2-
tailed) 
0.609 0.082 0.000 0.000 0.000 . 0.005 
VFQ 
Mental 
Health 
Score 
Correlation 
Coefficient 
.413* .967** .716** .719** .646** .551** 1.000 
Sig. (2-
tailed) 
0.045 0.000 0.000 0.000 0.001 0.005 . 
 
* Correlation is significant at the 0.05 level (2-tailed). 
**Correlation is significant at the 0.01 level (2-tailed). 
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Table 2c. Significant and non-Significant Spearman Correlations of Interest for the Type 2 Diabetic Group 
(N = 69) 
 
Spearman's rho SDSCA 
Composite 
score 
VFQ 
Item 3 
VFQ Mental 
Health 
Score 
VFQ 
Composite 
Score 
FCQ 
Vision 
Score 
FCQ 
Composite 
Score  
SDSCA 
Composite 
score 
Correlation 
Coefficient 
1.000 -0.153 -0.173 0.022 0.131 0.012 
Sig. (2-
tailed) 
. 0.210 0.156 0.861 0.285 0.924 
VFQ Item 3 Correlation 
Coefficient 
-0.153 1.000 .889** .446** -.596** -.636** 
Sig. (2-
tailed) 
0.210 . 0.000 0.000 0.000 0.000 
VFQ Mental 
Health 
Score 
Correlation 
Coefficient 
-0.173 .889** 1.000 .633** -.517** -.560** 
Sig. (2-
tailed) 
0.156 0.000 . 0.000 0.000 0.000 
VFQ 
Composite 
Score 
Correlation 
Coefficient 
0.022 .446** .633** 1.000 -.343** -.372** 
Sig. (2-
tailed) 
0.861 0.000 0.000 . 0.004 0.002 
FCQ Vision 
Score 
Correlation 
Coefficient 
0.131 -.596** -.517** -.343** 1.000 .815** 
Sig. (2-
tailed) 
0.285 0.000 0.000 0.004 . 0.000 
FCQ 
Composite 
Score  
Correlation 
Coefficient 
0.012 -.636** -.560** -.372** .815** 1.000 
Sig. (2-
tailed) 
0.924 0.000 0.000 0.002 0.000 . 
 
* Correlation is significant at the 0.05 level (2-tailed). 
**Correlation is significant at the 0.01 level (2-tailed). 
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Table 2d. Significant and non-Significant Spearman Correlations of Interest for the Unknown Diabetes Type 
Group (N = 7) 
 
Spearman's rho SDSCA 
Composite 
Score 
VFQ Item 
3 
VFQ 
Mental 
Health 
Score 
VFQ 
Composite 
Score 
FCQ 
Vision 
Score 
FCQ 
Composite 
Score  
SDSCA 
Composite 
Score 
Correlation 
Coefficient 
1.000 -0.468 -0.099 -0.036 0.182 0.144 
Sig. (2-
tailed) 
. 0.290 0.834 0.939 0.696 0.758 
VFQ Item 3 Correlation 
Coefficient 
-0.468 1.000 .774* 0.225 -0.686 -0.576 
Sig. (2-
tailed) 
0.290 . 0.041 0.628 0.089 0.176 
VFQ Mental 
Health 
Score 
Correlation 
Coefficient 
-0.099 .774* 1.000 0.571 -.903** -.915** 
Sig. (2-
tailed) 
0.834 0.041 . 0.180 0.005 0.004 
VFQ 
Composite 
Score 
Correlation 
Coefficient 
-0.036 0.225 0.571 1.000 -0.491 -0.577 
Sig. (2-
tailed) 
0.939 0.628 0.180 . 0.263 0.175 
FCQ Vision 
Score 
Correlation 
Coefficient 
0.182 -0.686 -.903** -0.491 1.000 .963** 
Sig. (2-
tailed) 
0.696 0.089 0.005 0.263 . 0.000 
FCQ 
Composite 
Score 
Correlation 
Coefficient 
0.144 -0.576 -.915** -0.577 .963** 1.000 
Sig. (2-
tailed) 
0.758 0.176 0.004 0.175 0.000 . 
 
* Correlation is significant at the 0.05 level (2-tailed). 
**Correlation is significant at the 0.01 level (2-tailed). 
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Table 2e. Significant and non-Significant Spearman Correlations of Interest for all Subjects Combined 
(N=100) 
 
Spearman's rho SDSCA 
Composite 
Score 
VFQ 
Item 3 
VFQ 
Mental 
Health 
Score 
VFQ 
Composite 
Score 
FCQ 
Vision 
Score 
FCQ 
Composite 
Score  
SDSCA 
Composite 
Score 
Correlation 
Coefficient 
1.000 -0.058 -0.068 0.082 0.089 -0.035 
Sig. (2-
tailed) 
. 0.565 0.503 0.419 0.381 0.727 
VFQ Item 3 Correlation 
Coefficient 
-0.058 1.000 .907** .491** -.585** -.593** 
Sig. (2-
tailed) 
0.565 . 0.000 0.000 0.000 0.000 
VFQ Mental 
Health 
Score 
Correlation 
Coefficient 
-0.068 .907** 1.000 .657** -.549** -.560** 
Sig. (2-
tailed) 
0.503 0.000 . 0.000 0.000 0.000 
VFQ 
Composite 
Score 
Correlation 
Coefficient 
0.082 .491** .657** 1.000 -.355** -.373** 
Sig. (2-
tailed) 
0.419 0.000 0.000 . 0.000 0.000 
FCQ Vision 
Score 
Correlation 
Coefficient 
0.089 -.585** -.549** -.355** 1.000 .806** 
Sig. (2-
tailed) 
0.381 0.000 0.000 0.000 . 0.000 
FCQ 
Composite 
Score  
Correlation 
Coefficient 
-0.035 -.593** -.560** -.373** .806** 1.000 
Sig. (2-
tailed) 
0.727 0.000 0.000 0.000 0.000 . 
 
* Correlation is significant at the 0.05 level (2-tailed). 
**Correlation is significant at the 0.01 level (2-tailed). 
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Table 3a.  Linear Regression Analysis - Relationship between VFQMental Health, VFQItem 3, VFQComposite, 
FCQVision, FCQComposite Scores (as Independent Variables) and the SDSCAComposite Score (as the Dependent 
Variable) 
  
Independent 
Variables 
R square 
Regression 
Coefficient (B) 
Standardized Regression 
Coefficient (Bs) 
Significance 
(2 tailed) 
Type 1 DM         
VFQMental Health 0.059 0.092 0.242 0.254 
VFQItem 3 0.231 0.118 0.481 0.017* 
VFQComposite 0.041 0.091 0.203 0.340 
FCQVision 0.021 -0.043 -0.144 0.501 
FCQComposite  0.089 -0.131 -0.298 0.157 
 Type 2 DM         
VFQMental Health 0.030 -0.188 -0.172 0.157 
VFQItem 3 0.029 -0.092 -0.169 0.164 
VFQComposite 0.011 -0.140 -0.106 0.385 
FCQVision 0.015 0.064 0.122 0.316 
FCQComposite  0.000 0.004 0.006 0.959 
All DM groups     
VFQMental Health 0.013 -0.100 -0.112 0.266 
VFQItem 3 0.012 -0.052 -0.108 0.283 
VFQComposite 0.002 -0.050 -.047 0.641 
FCQVision 0.009 0.046 0.096 0.341 
FCQComposite  0.000 -0.004 -0.006 0.953 
 
Dependent variable: SDSCAComposite Score 
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Table 3b. Multiple Regression Analysis - Effect of Fear of Other Diabetes Complications on the Relationship 
between Concern for Overall Eyesight and Self-care Behavior (Type 1 Diabetes Group only). 
 
Variable  R square 
Regression 
coefficient (B) 
Standardized Regression 
Coefficient (Ba) 
Significance 
(2 tailed) 
VFQ Items 
21,22,25,A12  
0.357 0.155 0.630 0.018* 
FCQLong term 0.240 0.105 0.425 0.069 
FCQVision 0.243 0.134 0.543 0.022* 
FCQHeart 0.247 0.108 0.439 0.040* 
FCQKidney 0.242 0.125 0.507 0.017* 
FCQStroke 0.285 0.109 0.442 0.028* 
FCQBlood Glucose 0.252 0.111 0.450 0.030* 
FCQCirculation 0.275 0.093 0.378 0.083 
FCQComposite 0.237 0.108 0.439 0.056 
 
Independent Variable:  VFQItem 3 Score 
Dependent Variable:  SDSCAComposite Score 
*Relationship between VFQItem 3 Score and SDSCAComposite Score remains statistically significant when indicated 
continuous variables are controlled for. 
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Table 4.  ANCOVA - Determining the Effect of Confounding Variables on the Association between      
VFQItem 3 scores and SDSCAComposite Scores. 
 
F-ratio: Ratio of the average variability in the data that each respect model can explain to the average variability 
unexplained by the same model 
ŋ2model : Total variance of each respective model 
ŋ2VFQ_3:  Proportion of variance in SDSCAComposite score attributable to VFQItem 3 score in each respective model 
Effect size (r): Effect size of VFQItem 3 score in each respective model 
P: Statistical significance of the relationship between VFQItem 3 and SDSCAComposite scores in each respective model 
Dependent Variable: SDSCAComposite Score 
Independent Variable: VFQItem 3 Score 
*Relationship between SDSCAComposite score and VFQItem 3 score remains statistically significant with the indicated 
categorical variables are adjusted for. 
aLevene's test of equality of variances not met. 
Factor 
F ratio  
(dfM, dfR) 
R2model 
(ŋ2model) 
ŋ2VFQ_3 Effect size (r) P  
None 6.620 (1,22) 0.231 0.231 0.481 0.017* 
Age 6.198 (1,20) 0.290 0.220 0.486 0.022* 
Gender 6.646 (1,21) 0.250 0.237 0.490 0.018* 
Employment Statusa 2.973 (1,19) 0.342 0.103 0.368 0.101 
Marital Status 6.162 91,21) 0.232 0.225 0.476 0.002* 
Health Insurance 4.980 (1,16) 0.409 0.184 0.489 0.040* 
Years of DM 6.329 (1,21) 0.249 0.166 0.481 0.020* 
Type of Medication 6.756 (1,20) 0.510 0.166 0.502 0.017* 
Diabetic Retinopathy 4.274 (1,21) 0.275 0.148 0.411 0.051 
Laser Therapy for DR 4.650 (1,21) 0.241 0.168 0.425 0.043* 
Presbyopia (Glasses for 
Near Vision) 
9.441 (1,21) 0.351 0.292 0.557 0.006* 
All 10 factors 0.253 (1,4) 0.877 0.008 0.244 0.641 
      
Macular Degeneration 7.573 (1,21) 0.267 0.265 0.515 0.012* 
Myopia (Glasses needed 
for Distant Vision) 
6.407 (1,21) 0.389 0.187 0.483 0.019* 
Cataract 6.933 (1,21) 0.262 0.243 0.498 0.016* 
Glaucoma 8.699 (1,21) 0.335 0.276 0.541 0.008* 
Cataract Surgery 6.489 (1,21) 0.236 0.236 0.485 0.019* 
All 8 eye-related factors 8.146 (1,14) 0.692 0.179 0.606 0.013* 
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Table 5a. Relationship Between HgA1c and SDSCAComposite, FCQComposite, FCQVision, VFQMental Health and 
VFQComposite Scores  
 
  
F-ratioCombined  
(dfM, dfR) Sig. (2-tailed) 
F-ratioLinear  
(dfM, dfR) Sig. (2-tailed) 
Type   1 DM  
SDSCAComposite  0.319 (4,15) 0.861 0.106 (1,15) 0.749 
FCQComposite  0.310 (4,15) 0.867 0.003 (1,15) 0.957 
FCQVision  0.760 (4, 15) 0.567 1.76 (1,15) 0.205 
VFQMental Health  1.02 (4,15) 0.430 0.352 (1, 15) 0.562 
VFQComposite  1.72 (4,15) 0.198 0.353 (1, 15) 0.561 
Type 2 DM 
SDSCAComposite  0.994 (4,53) 0.419 0.234 (1,53) 0.631 
FCQComposite  5.94 (4,53) 0.001* 7.80 (1,53) 0.007* 
FCQVision  5.06(4,53) 0.002* 7.56 (1,53) 0.008* 
VFQMental Health  1.25 (4,53) .300 0.443 (1,53) 0.509 
VFQ Composite  0.682 (4,53) .607 0.394 (1,53) 0.533 
All Groups Combined 
SDSCAComposite  0.680 (4, 79) 0.608 0.141 (1, 79) 0.708 
FCQComposite 2.601 (4, 79) 0.042* 2.994 (1, 79) 0.087 
FCQVision  1.58 (4, 79)  0.188 0.835 (1, 79) 0.364 
VFQMental Health  0.621 (4, 79) 0.649 0.847 (1, 79) 0.360 
VFQComposite  0.267 (4, 79) 0.898 0.832 (1, 79) 0.364 
 
*Statistically Significant 
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Table  5b. Effect sizes of Relationships between FCQ Composite and Subscale Scores and HgA1c levels for the Type 2 
Diabetic group and all Groups Combined. 
 
FCQ Subscale Score 
F-ratioCombined 
(dfM, dfR, sig) 
F-ratioLinear 
(dfM, dfR, sig) Effect size (ω) 
Type 2 DM    
FCQComposite 5.942 (4, 53, 0.003*) 7.80 (1, 53, 0.007*) 0.504* 
FCQBlood Glucose 5.88 (4, 53, 0.001*) 9.60 (1, 53, 0.003*)  0.502* 
FCQVision 5.06 (4, 53, 0.002*) 7.56 (1, 53, 0.008*) 0.468* 
FCQStroke 5.00 (4, 53, 0.002*) 5.47 (1, 53, 0.023*) 0.465* 
FCQLong Term 4.67 (4, 53, 0.003*) 5.78 (1, 53, 0.020*) 0.449* 
FCQ Heart 4.80 (4, 53, 0.002*) 5.88 (1, 53, 0.019*) 0.445* 
FCQKidney 2.88 (4, 53, 0.031*) 3.77 (1, 53, 0.058) 0.339* 
FCQCirculation 2.00 (4, 53, 0.108) 1.03 (1, 53, 0.314) 0.254 
All DM Groups    
FCQComposite 2.60 (4, 79, 0.042*) 2.99 (1, 79, 0.087) 0.283* 
FCQBlood Glucose 3.09 (4, 79, 0.020*) 5.34 (1, 79, 0.023*) 0.323* 
FCQStroke 4.83 (4, 79, 0.002*) 1.81 (1, 79, 0.182) 0.437* 
 
 
*Statistically Significant 
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Table 5c. Planned Contrast Results for Comparison of FCQ Composite and Subscale Scores Between 
HgA1c Categories in the Type 2 Diabetes Group and All Groups Combined. 
 
FCQ Subscale 
Score Contrasta 
Value of 
Contrast 
Std. 
Error t dfR Sig. (2-tailed) 
Contrast 
Effect size (r) 
Type 2  DM        
FCQLong term 1 83.83 46.44 1.805 53 0.077 0.241 
4 42.54 12.06 3.527 53 0.001* 0.436* 
FCQVision 1 105.39 52.44 2.009 53 0.050* 0.266* 
4 52.36 13.62 3.843 53 <0.001* 0.467* 
FCQHeart 1 96.61 50.38 1.918 53 0.061 0.255 
4 47.98 13.09 3.667 53 0.001* 0.450* 
FCQKidney 1 100.20 57.51 1.742 53 0.087 0.233 
4 38.27 14.94 2.562 53 0.013* 0.332* 
FCQStroke 1 88.75 46.84 1.895 53 0.064 0.252 
4 45.79 12.17 3.763 53 <0.001* 0.459* 
FCQBlood Glucose 1 118.29 50.59 2.338 53 0.023* 0.306* 
4 53.37 13.14 4.062 53 <0.001* 0.487* 
FCQComposite 1 89.17 41.43 2.153 53 0.036* 0.284* 
4 44.85 10.76 4.168 53 <0.001* 0.497* 
All DM Groups        
FCQComposite 1 48.7 37.7 1.290 79 0.201 0.144 
 4 25.9 9.32 2.775 79 0.007* 0.298* 
FCQStroke 1 40.50 40.94 0.989 79 0.326 0.111 
 4 38.16 10.12 3.772 79 <0.001* 0.391* 
FCQBlood Glucose 1 80.13 47.85 1.675 79 0.098 0.185 
 4 33.18 11.82 2.806 79 0.006* 0.301* 
 
* Statistically significant 
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aContrast Coefficients 
 
Contrast 
What was your most recent HbA1c level? 
<5.0 - 5.9 6.0 - 6.9 7.0 - 7.9 8.0-9.0 >9.0 
1 -4 1 1 1 1 
2 0 -3 1 1 1 
3 0 0 -2 1 1 
4 0 0 0 -1 1 
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8. Figures 
 
Figure 1.  Linear Regression Relationship Between VFQItem 3 and SDSCAComposite Score for the Type 1 
Diabetes Group 
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9. APPENDIX: QUESTIONNAIRES 
 
I. Demographic Information Sheet 
 
Please complete the following questions as best you can to help us learn more about who you are. Note that 
none of the information you provide will be shared with unauthorized individuals. Thank you for your 
participation. 
 
1. Have you participated in this study before? 
a. Yes 
b. No 
 
If  ‘Yes’ please return the questionnaire packet to the individual who gave it to you. 
 
2. What is your age?  ________________years. 
 
3. What is your gender?  
a. Male 
b. Female 
 
4. What language do you speak most in your home? 
a. English 
b. Spanish 
c. Other (please specify):_______________________ 
 
5. What is the highest level of formal education you have completed? 
a. Elementary school 
b. High school or equivalent 
c. Vocation/Technical School (2 years) 
d. Some College 
e. Bachelor’s Degree (4 years of College) 
f. Master’s Degree 
g. Doctoral Degree or equivalent 
h. Professional Degree (MD, JD etc) 
i. Other (please specify):_________________________ 
 
6. What is your race? 
a. African American 
b. Asian 
c. Caucasian 
d. Hispanic 
e. Multi-racial 
f. Other (please specify):________________________ 
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7. How would you describe your current employment status? 
a. Employed (full time) 
b. Employed (part time) 
c. Unemployed (but job hunting) 
d. Unemployed (not job hunting) 
e. Disabled ( unable to work) 
f. Retired 
 
8. What is your yearly income level? 
a. <$30,000 
b. $30,000 - $60,000  
c. $60,000 - $100,000 
d. $100,000 and greater 
 
9. What is your current marital status? 
a. Single 
b. Married 
c. Divorced 
d. Separated 
e. Widowed 
f. Civil union 
g. Living with another 
 
 
10. What kind of health insurance do you have (Please circle one)? 
a. Medicare only 
b. Medicaid only 
c. Private only 
d. Medicare and Medicaid 
e. Medicare and Private 
f. Medicaid and Private 
g. None/self pay 
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II. Health Information Sheet 
 
Please complete this questionnaire as best you can to help us understand more about your health.  Note 
that none of the information you provide will be shared with unauthorized individuals. Thank you for your 
participation. 
 
1. What type of diabetes do you have? 
a. Type 1 Diabetes 
b. Type 2 Diabetes 
c. Gestational Diabetes 
d. Other (Please specify):____________________________________ 
e. Don’t know 
 
   
2. When were you first told you have diabetes? (Circle one) 
       Less than 5 years ago/5-10 years ago/10-20 years ago/More than 20 years ago 
 
   
3. Are you using any medication for diabetes? 
 
Yes No Don’t know 
4. If you answered ‘Yes’ to question (3), what kind of medication are you using? 
(Circle all that apply) 
a. Pills/tablets 
b. Injection (Insulin) 
c. Pump (Insulin) 
d. Other (Please Specify):___________________________________ 
e. Don’t know 
 
   
5. What was your most recent HbA1c level (within the past 2-3 months)?  
a. <  5.0 
b. 5.0 – 5.9 
c. 6.0 – 6.9 
d. 7.0 – 7.9 
e. 8.0 – 9.0 
f. >  9.0 
g. Don’t know 
 
   
6. Have you ever been told you have kidney problems because of diabetes? 
 
Yes No Don’t know 
 
7. If you answered ‘Yes’ to question (6) please answer the following:    
a. Are you on dialysis? 
 
Yes No Don’t know 
b. Have you ever received a kidney transplant? Yes No Don’t know 
 
8. Have you ever been told you have diabetic retinopathy or diabetic eye Yes No Don’t know 
57 
 
disease?  
a. If ‘Yes’ have you ever had laser treatments for your diabetic eye disease? 
 
Yes No Don’t know 
 
9. Do you wear glasses to help you see things that are far away? Yes No Don’t know 
10. Do you wear glasses to help you see things up close? Yes No Don’t know 
11. Have you ever been told you have macular degeneration? 
 
Yes No Don’t know 
12. If you answered ‘Yes’ to question (11), have you received or do you use any of 
the following treatments? (Circle all that apply) 
a. Vitamins (taken by mouth) 
b. Injections into the eye 
c. Laser therapy 
d. Other ( Please Specify): _________________________ 
e. Don’t know 
 
   
13. Have you ever been told you have cataracts or clouded eye lenses? 
 
Yes No Don’t know 
14. If you answered ‘Yes’ to question (13), have you ever had surgery to have the 
cataracts removed?  
 
Yes No Don’t know 
15. Have you ever been told you have glaucoma or high eye pressure? 
 
Yes No Don’t know 
16. If you answered ‘Yes’ to question (15), have you received or do you use any of  
the following treatments? (Circle all that apply) 
a. Eye drops 
b. Surgery 
c. Laser therapy 
d. Other (Please specify):______________________________ 
e. Don’t know 
 
   
17. When was your last eye examination? (circle one) 
a. I have never had an eye exam 
b. Within the last year 
c. 2 – 5 years ago 
d. Greater than 5 years ago 
e. I cannot remember 
 
   
18. Have you ever had an eye examination that included having eye drops put in 
your eyes to dilate your pupils? 
 
 
Yes 
 
No 
 
Don’t know 
19. Have you ever had a stroke? 
 
Yes No Don’t know 
20. Have you ever been told you have heart disease? Yes No Don’t know 
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21. If you answered ‘Yes’ to question (20) please answer the following:    
a. Have you ever had a heart attack? 
 
Yes No Don’t know 
b. Do you experience chest pain when you exercise or walk long distances? 
 
Yes No Don’t know 
22. Have you ever been told you have poor circulation? 
 
Yes No Don’t know 
23. If you answered ‘Yes’ to question (19) please answer the following:    
a. Do you have sores on your legs/feet that do not heal? 
 
Yes No Don’t know 
b. Has any part of your body been amputated because of poor circulation? 
 
Yes No Don’t know 
24. Does anyone in your family have diabetes? 
 
Yes No Don’t know 
25. If you answered ‘Yes’ to question (24) please answer the following: 
 
   
a. Please specify how this (these)  family member(s) is(are) related to you (e.g. 
mother, brother, sister etc) :______________________________ 
 
b. Has (have) this (these) family members experienced any of the following 
diabetes complications? 
i. Heart disease 
ii. Kidney disease 
iii. Diabetic retinopathy/diabetic eye disease 
iv. Stroke 
v.  Blindness 
vi. Amputation of a limb 
vii. Other (Please specify): _______________________ 
viii. Don’t know 
 
   
59 
 
III. Summary of Diabetes Self-Care Activities 
 
The questions below ask you about your diabetes self-care activities during the past 7 days. If you were 
sick during the past 7 days, please think back to the last 7 days that you were not sick. 
 
    Diet 
1. How many of the last SEVEN DAYS have you followed a healthy eating plan? 
0 1 2 3 4 5 6 7 
 
2. On average, over the past month, how many DAYS PER WEEK have you followed your eating 
plan? 
0 1 2 3 4 5 6 7 
 
3. On how many of the last SEVEN DAYS did you eat five or more servings of fruits and vegetables? 
0 1 2 3 4 5 6 7 
 
4. On how many of the last SEVEN DAYS did you eat high fat foods such as red meat or full-fat dairy 
products? 
0 1 2 3 4 5 6 7 
 
 
     Exercise 
 
5. On how many of the last SEVEN DAYS did you participate in at least 30 minutes of physical 
activity? (Total minutes of continuous activity, including walking). 
0 1 2 3 4 5 6 7 
 
6. On how many of the last SEVEN DAYS did you participate in a specific exercise session (such as 
swimming, walking, biking) other than what you do around the house or as part of your work? 
0 1 2 3 4 5 6 7 
 
      Blood Sugar Testing 
 
7. On how many of the last SEVEN DAYS did you test your blood sugar? 
0 1 2 3 4 5 6 7 
 
8. On how many of the last SEVEN DAYS did you test your blood sugar the number of times 
recommended by your health care provider? 
0 1 2 3 4 5 6 7 
 
 
      Foot  Care 
 
9. On how many of the last SEVEN DAYS did you check your feet? 
0 1 2 3 4 5 6 7 
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10. On how many of the last SEVEN DAYS did you inspect the inside of your shoes? 
0 1 2 3 4 5 6 7 
 
      Smoking 
 
11.   Have you smoked a cigarette—even one puff—during the past SEVEN DAYS? 
0. No 
1. Yes.  
 
If Yes, how many cigarettes did you smoke on an average day? 
Number of cigarettes: 
 
     Medications 
 
12. On how many of the last SEVEN DAYS, did you take your recommended diabetes medication? 
0 1 2 3 4 5 6 7 
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IV. Fear of complications questionnaire (FCQ) 
This questionnaire is designed to help us understand how you feel about your Diabetes and how it affects 
you, particularly in the long-term.  Please answer the following questions as honestly as possible.  Your 
answers will be kept in strictest confidence. 
1. I feel afraid of long-term complications of Diabetes 
Very Moderately A little Not at all 
2. I worry about losing my eyesight because of Diabetes 
All the time Frequently Occasionally Never 
3. I worry that having Diabetes increases my chances of heart disease 
All the time Frequently Occasionally Never 
4. I am afraid I will need a kidney transplant one day 
Very Moderately A little Not at all 
 
5. I am afraid of developing long-term complications as a result of frequent high blood sugars 
All the time Frequently Occasionally Never 
6. I am afraid that I may need kidney dialysis one day 
Never Occasionally Frequently Constantly 
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7. I am afraid that I will develop kidney problems one day 
All the time Frequently Occasionally Never 
8. How often do you think about long-term complications of Diabetes? 
Hardly ever Occasionally Frequently All the time 
9. I worry that I might be at a higher risk for having a stroke 
All the time Frequently Occasionally Never 
10. Do you ever worry about your future health? 
Not at all Occasionally Frequently All the time 
11. I worry that the Diabetes Specialist will find something wrong with my eyes 
Not at all Occasionally Frequently Constantly 
 
12. Do you worry about future problems when your blood sugars are erratic? 
Not at all Occasionally Frequently All the time 
13. I am scared that Diabetes could affect my feet 
Very Moderately A little Not at all 
14. I'm scared of having a heart attack in the future 
Not at all A little scared Moderately scared Very scared 
15. I worry about developing problems with circulation 
Never Occasionally Frequently All the time 
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V. Visual Functioning Questionnaire (VFQ) 
 
PB/IA 
National Eye Institute Visual  
Functioning Questionnaire - 25 
(VFQ-25) 
 
version 2000 
 
 
 
(INTERVIEWER ADMINISTERED FORMAT) 
 
 
 
January 2000 
 
 
 
RAND hereby grants permission to use the "National Eye Institute Visual Functioning Questionnaire 25 (VFQ-25) 
July 1996, in accordance with the following conditions which shall be assumed by all to have been agreed to as a 
consequence of accepting and using this document: 
 
1. Changes to the NEI VFQ-25 - July 1996 may be made without the written permission of RAND. However, all 
such 
changes shall be clearly identified as having been made by the recipient. 
 
2. The user of this NEI VFQ-25 - July 1996 accepts full responsibility, and agrees to hold RAND harmless, for the 
accuracy of any translations of the NEI VFQ-25 Test Version - July 1996 into another language and for any errors, 
omissions, misinterpretations, or consequences thereof. 
 
3. The user of this NEI VFQ-25 - July 1996 accepts full responsibility, and agrees to hold RAND harmless, for any 
consequences resulting from the use of the NEI VFQ-25. 
 
4. The user of the NEI VFQ-25 - July 1996 will provide a credit line when printing and distributing this document 
or 
in publications of results or analyses based on this instrument acknowledging that it was developed at RAND 
under 
the sponsorship of the National Eye Institute. 
 
5. No further written permission is needed for use of this NEI VFQ-25 - July 1996. 
 
7/29/96 
 
© R 1996 
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Instructions: 
I’m going to read you some statements about problems which involve your vision 
or feelings that you have about your vision condition. After each question I will 
read you a list of possible answers. Please choose the response that best 
describes your situation. 
 
Please answer all the questions as if you were wearing your glasses or contact 
lenses (if any). 
 
Please take as much time as you need to answer each question. All your 
answers are confidential. In order for this survey to improve our knowledge 
about vision problems and how they affect your quality of life, your answers must 
be as accurate as possible. Remember, if you wear glasses or contact lenses 
for a particular activity, please answer all of the following questions as though 
you were wearing them. 
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Visual Functioning Questionnaire - 25 
 
PART 1 - GENERAL HEALTH AND VISION 
 
1. In general, would you say your overall health is*: 
(Circle One) 
READ CATEGORIES:          Excellent 
........................... 1 
    Very Good......................... 2 
Good.................................. 3 
Fair..................................... 4 
Poor................................... 5 
 
 
 
 
2. At the present time, would you say your eyesight using both eyes 
(with glasses or contact lenses, if you wear them) is excellent, good, 
fair, poor, or very poor or are you completely blind? 
(Circle One) 
READ CATEGORIES:          Excellent 
........................... 1 
Good.................................. 2 
Fair..................................... 3 
Poor................................... 4 
Very Poor .......................... 5 
Completely Blind.............. 6 
 
 
 
 
 
 
 
______________________ 
* Skip Question 1 when the VFQ-25 is administered at the same time as the SF-36 or 
RAND 36-Item Health Survey 1.0 
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3. How much of the time do you worry about your eyesight? 
(Circle One) 
READ CATEGORIES:     None of the time.......................... 1 
A little of the time........................ 2 
Some of the time......................... 3 
Most of the time .......................... 4 
All of the time? ............................ 5 
 
4. How much pain or discomfort have you had in and around your eyes 
(for example, burning, itching, or aching)? Would you say it is: 
(Circle One) 
READ CATEGORIES:          None 
.................................. 1 
Mild.................................... 2 
Moderate ........................... 3 
Severe, or.......................... 4 
Very severe?..................... 5 
 
 
PART 2 - DIFFICULTY WITH ACTIVITIES 
 
The next questions are about how much difficulty, if any, you have doing 
certain activities wearing your glasses or contact lenses if you use them 
for that activity. 
 
5. How much difficulty do you have reading ordinary print in 
newspapers? Would you say you have: 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
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6. How much difficulty do you have doing work or hobbies that require 
you to see well up close, such as cooking, sewing, fixing things 
around the house, or using hand tools? Would you say: 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
 
 
7. Because of your eyesight, how much difficulty do you have finding 
something on a crowded shelf? 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
 
 
8. How much difficulty do you have reading street signs or the names of 
stores? 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
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9. Because of your eyesight, how much difficulty do you have going 
down steps, stairs, or curbs in dim light or at night? 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
 
 
10. Because of your eyesight, how much difficulty do you have noticing 
objects off to the side while you are walking along? 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
 
 
11. Because of your eyesight, how much difficulty do you have seeing 
how people react to things you say? 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
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12. Because of your eyesight, how much difficulty do you have picking 
out and matching your own clothes? 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
 
 
13. Because of your eyesight, how much difficulty do you have visiting 
with people in their homes, at parties, or in restaurants ? 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ...................................... 6 
 
 
14. Because of your eyesight, how much difficulty do you have going out 
to see movies, plays, or sports events? 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................................... 1 
A little difficulty...................................................... 2 
Moderate difficulty................................................. 3 
Extreme difficulty................................................... 4 
Stopped doing this because of your eyesight .... 5 
Stopped doing this for other reasons or not 
interested in doing this ..................................... 6 
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15. Now, I’d like to ask about driving a car. Are you currently driving, at 
least once in a while? 
(Circle One) 
Yes .................... 1 Skip To Q 15c 
 
No...................... 2 
 
 
 
15a. IF NO, ASK: Have you never driven a car or have you given up 
driving? 
(Circle One) 
Never drove ...... 1 Skip To Part 3, Q 17 
 
Gave up............. 2 
 
 
15b. IF GAVE UP DRIVING: Was that mainly because of your 
eyesight, mainly for some other reason, or because of both your 
eyesight and other reasons? 
(Circle One) 
Mainly eyesight ................................ 1 Skip To Part 3, Q 17 
 
Mainly other reasons ....................... 2 Skip To Part 3, Q 17 
 
Both eyesight and other reasons ... 3 Skip To Part 3, Q 17 
 
 
15c. IF CURRENTLY DRIVING: How much difficulty do you have 
driving during the daytime in familiar places? Would you say 
you have: 
(Circle One) 
No difficulty at all ............................. 1 
A little difficulty ................................ 2 
Moderate difficulty ........................... 3 
Extreme difficulty ............................. 4 
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16. How much difficulty do you have driving at night? Would you say you 
have: (READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................... 1 
A little difficulty...................................... 2 
Moderate difficulty................................. 3 
Extreme difficulty................................... 4 
Have you stopped doing this because 
of your eyesight ................................ 5 
Have you stopped doing this for other 
reasons or are you not interested in 
doing this .......................................... 6 
 
 
16a. How much difficulty do you have driving in difficult conditions, such 
as in bad weather, during rush hour, on the freeway, or in city traffic? 
Would you say you have: 
(READ CATEGORIES AS NEEDED) 
(Circle One) 
No difficulty at all................................... 1 
A little difficulty...................................... 2 
Moderate difficulty................................. 3 
Extreme difficulty................................... 4 
Have you stopped doing this because 
of your eyesight ................................ 5 
Have you stopped doing this for other 
reasons or are you not interested in 
doing this .......................................... 6 
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PART 3: RESPONSES TO VISION PROBLEMS 
The next questions are about how things you do may be affected by your 
vision. For each one, I’d like you to tell me if this is true for you all, most, 
some, a little, or none of the time. 
 
(Circle One On Each Line) 
 
READ CATEGORIES:  
 
All of 
the time 
 
Most of 
the time 
 
Some 
of the 
time 
 
A little 
of the 
time 
 
None of 
the time 
 
17. Do you accomplish less 
than you would like 
because of your vision? 
 
1 2 3 4 5 
18. Are you limited in how 
long you can work or do 
other activities because of 
your vision? ................... 
 
1 2 3 4 5 
19. How much does pain or 
discomfort in or around 
your eyes, for example, 
burning, itching, or 
aching, keep you from 
doing what you’d like to 
be doing? Would you say: 1 2 3 4 5 
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For each of the following statements, please tell me if it is definitely true, 
mostly true, mostly false, or definitely false for you or you are not sure. 
 
 (Circle One On Each Line) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© R 1996 
READ CATEGORIES:  
 
Definitely 
True 
 
Mostly 
True 
 
Not 
Sure 
 
Mostly 
False 
 
Definitely 
False 
 
20. I stay home most of the time 
because of my eyesight.....  
 
1 2 3 4 5 
21. I feel frustrated a lot of the 
time because of my eyesight J. 
 
1 2 3 4 5 
22. I have much less control 
over what I do, because of 
my eyesight. ....................... 
 
1 2 3 4 5 
23. Because of my eyesight, I 
have to rely too much on 
what other people tell me. . 
 
1 2 3 4 5 
24. I need a lot of help from 
others because of my 
eyesight............................... 
 
1 2 3 4 5 
25. I worry about doing things 
that will embarrass myself 
or others, because of my 
eyesight............................... 
 
1 2 3 4 5 
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SUBSCALES: WELL-BEING/DISTRESS (#A12)  
 
The next questions are about how you deal with your vision. For each 
statement, please tell me if it is definitely true, mostly true, mostly false, or 
definitely false for you or you don’t know. 
(Circle One On Each Line) 
 
READ CATEGORIES:  
 
Definitely 
True 
 
Mostly 
True 
 
Not 
Sure 
 
Mostly 
False 
 
Definitely 
False 
 
A12. I am often irritable because 
of my eyesight. ................... 
 
1 2 3 4 5 
 
 
 
 
That’s the end of the interview. Thank you very much for your 
time and your help. 
 
 
 
 
 
 
 
 
 
 
© R 1996 
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